sentence	label
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The use of local anesthetics containing epinephrine, or @DRUG$ to patients receiving @DRUG$ , tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Similarly dialyzed were phenobarbital, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , @DRUG$/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus @DRUG$ ) without receiving @DRUG$ therapy .	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on atenolol than in patients on no other @DRUG$ therapy.	DDI-false
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , @DRUG$ , @DRUG$ , antiemetics, sedatives, sedatives).	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat .	DDI-effect
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or CHOP-like regimen (i.e., cyclophosphamide, doxorubicin), @DRUG$ , and Prednisone with @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , @DRUG$ or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$ , @DRUG$ and glutethimide ;	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with @DRUG$ • Accompanied by anxiolytics, hypnotic agents and @DRUG$ ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent @DRUG$ such as @DRUG$.	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite @DRUG$ were unaffected following co-administration with Acamprosate.	DDI-false
Corticosteroids , @DRUG$ and @DRUG$ : Concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
Coingestion of acetaminophen with theophylline , phenobarbital with acetaminophen , and @DRUG$ with @DRUG$ At high to toxic concentrations, binding of the target medication is reduced.	DDI-effect
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or @DRUG$.	DDI-effect
Potassium-sparing diuretics (e.g. spironolactone, @DRUG$ , or @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
@DRUG$ and @DRUG$: a drug interaction.	DDI-int
@DRUG$ (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ • no significant impact on the @DRUG$ pharmacokinetics .	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and @DRUG$ chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or with a CHOP-like regimen (i.e. cyclophosphamide, doxorubicin, @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Like ibogaine ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of @DRUG$ and @DRUG$ and the oral self-administration of ethanol and nicotine in rats ;	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , @DRUG$ ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal .	DDI-false
- corticosteroids, methylxanthine and @DRUG$ : Accompanying treatment with @DRUG$ , steroids , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
Like @DRUG$ ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats ;	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , methyldopa, nitrates, calcium blockers, @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another @DRUG$ and @DRUG$ but may be seen after several months.	DDI-effect
Other concomitant therapies : In clinical trials, the safety profile in patients with @DRUG$ concomitantly with anxiolytics , hypnotics and sedatives ( including @DRUG$ The use of placebo with these concomitant drugs was similar to that of subjects who used placebo (e. g., non-opioid analgesics).	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , @DRUG$.	DDI-effect
Concurrent administration of @DRUG$ (used to treat hypotension associated with birth blocks) and @DRUG$ may cause severe , persistent hypertension or cerebrovascular accidents .	DDI-effect
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
In EM patients treated with paroxetine, or @DRUG$ , the AUC of atomoxetine is approximately 6- to 8-fold and Css , max is about 3- to 4-fold greater than @DRUG$ alone .	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
acetaminophen/@DRUG$ , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
Agents Causing Renin Release : The antihypertensive effect of enalapril and @DRUG$ IV is augmented by antihypertensive agents that cause renin release ( e.g. , @DRUG$ ) .	DDI-effect
♪ Drugs that can change ♪ @DRUG$ Plasma concentrations Drugs that may increase @DRUG$ Plasma concentrations: Caution should be exercised when gleevec is administered with inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Both the toxicity of filipin and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Therefore, interactions may occur after co-administration of psychotropic drugs (e.g. narcotics, analgesics, antiemetics, @DRUG$ , @DRUG$ ) .	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , @DRUG$ ) , myelotoxic ( e.g. , @DRUG$ Chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Atromide-S can be acidic medicines such as @DRUG$ or @DRUG$ From their binding sites.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Although drug interaction studies have not been conducted, it has been established that: @DRUG$ or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients ( N=180 ) receiving Betaseron .	DDI-false
Acid-catalyzed ethanolysis of @DRUG$ in anhydrous and aqueous @DRUG$ solutions.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
• Lack of an effect of azithromycin on the disposition of @DRUG$ and @DRUG$ In HIV-infected patients.	DDI-false
Non-selective MAO inhibitors including @DRUG$, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV together with beta-adrenergic blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralacin, @DRUG$ and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
These results suggest that both @DRUG$ and @DRUG$ The proliferation of prostate epithelium, and possibly other glucocorticoids and retinoids, may be controlled by dose-dependent changes in insulin and EGF activity.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Two groups ( SH/DA ; SH/FA ) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol , @DRUG$ , higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages ;	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, @DRUG$, rifampin, phenobarbital or St.	DDI-false
Primary and secondary @DRUG$ Weaknesses represent the only indication for physiological oral @DRUG$ therapy .	DDI-false
Quetiapine fumarate ('@DRUG$') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Isocarboxazid should be administered with caution to patients receiving @DRUG$ (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective @DRUG$ may cause hypertension.	DDI-effect
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Administering @DRUG$ together with @DRUG$ (100-500 microM) inhibited InsP(3)-induced responses (both Ca(2+) and current responses) in a dose-dependent fashion.	DDI-effect
@DRUG$ and Tricyclic Antidepressants : @DRUG$ In patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, the use should be carried out with extreme caution as the effect of formoterol on the cardiovascular system may be enhanced by these agents.	DDI-false
These results suggest that the hepatoxicity of @DRUG$ In alcoholic beverages, interactions with its congeners and @DRUG$ ;	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing a high sequential dose. @DRUG$ and antineoplastic agents , specifically , dacarbazine , @DRUG$ , tamoxifen and interferon alpha.	DDI-effect
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Therefore , the combined use of @DRUG$ with @DRUG$ In general, it should be avoided.	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Although @DRUG$ have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ may displace acidic drugs such as @DRUG$ or tolbutamide from their binding sites.	DDI-mechanism
These results suggest that both dexamethasone and dexamethasone @DRUG$ , and possibly other @DRUG$ Prostate epithelium proliferation can be regulated by dose-dependent changes in insulin and EGF activity.	DDI-false
Slow-channel calcium blockers , such as @DRUG$ , diltiazem and @DRUG$ , inhibit platelet activation in vitro, and reduce platelet adhesion intravascularly.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , @DRUG$ , erythromycin , @DRUG$ ) .	DDI-false
@DRUG$ is the first @DRUG$ to be approved for clinical use , and has been studied extensively in humans since 1986 .	DDI-false
It differs structurally from the other currently available @DRUG$ ( @DRUG$ , simvastatin , and pravastatin ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , @DRUG$ Nitrates, calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Potassium-sparing diuretics (e.g. @DRUG$ , @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
@DRUG$ (e.g. spironolactone, triamterene or @DRUG$ ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ 14 The effect of 0.25 mg @DRUG$ The drug metabolism in MS patients is not known.	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of @DRUG$, increased Gleevec oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-mechanism
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$ may displace acidic drugs such as phenytoin or @DRUG$ from their binding sites.	DDI-mechanism
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
* Chloramphenicol has shown itself to be antagonistic to @DRUG$ , including @DRUG$ , based on in vitro studies and time kill curves with enteric gram-negative bacilli .	DDI-false
Therefore, interactions may occur after concomitant administration of psychotropic medicinal products (e. g. @DRUG$ , analgesics, antiemetics, @DRUG$ , tranquilizers ) .	DDI-false
@DRUG$ • can cause acidic drugs such as: @DRUG$ or tolbutamide from their binding sites .	DDI-mechanism
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ And prednisone with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
Both ibogaine and @DRUG$ block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
Moreover , additional interaction studies with @DRUG$ The use of fluvastatin and propranolol showed no effect on plasma fluvastatin levels and chronic use in a patient population that: @DRUG$ The bioavailability of digoxin compared to control data was not different.	DDI-false
Other medicines: medicines such as quinidine, disopyramide, procainamide, @DRUG$ , @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
• Concomitant use of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
@DRUG$, lidocaine, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , @DRUG$ , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
apomorphine - prior ingestion of @DRUG$ may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$, but not @DRUG$, decreases heart rate at high doses.	DDI-false
It is important that patients understand how to @DRUG$   ( @DRUG$ ) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking .	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent diuretics such as @DRUG$.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
@DRUG$ , lidocaine, phenobarbital, quinidine, @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations .	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The effects of DCG-IV and @DRUG$ upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
Acetaminophen , @DRUG$ , phenobarbital , quinidine , theophylline , and @DRUG$ The pooled human serum was added at therapeutic concentrations.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
- Non-selective MAO inhibitors including tranylcypromin sulfate, phenylzinsulfate and @DRUG$ HC1 : Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension .	DDI-false
The following eight target drug/added drug combinations were studied: @DRUG$/@DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Both @DRUG$ and @DRUG$ enhance the locomotor and/or stereotypic effects of stimulants.	DDI-false
Physiological oral @DRUG$ The supplementation ( 5 mg/kg/day ) is simple and can be done in the diet or with @DRUG$s, with practically only one contraindication: open kidney failure.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In a clinical pharmacology study, @DRUG$ or sulindac was administered to hypertensive patients receiving @DRUG$.	DDI-false
@DRUG$, lidocaine, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Drugs that may alter @DRUG$ Plasma concentrations Drugs that may increase plasma concentrations of imatinib: Caution is recommended when gleevec is administered with inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, erythromycin, @DRUG$ ) .	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Other cardiovascular agents : enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ 1 micrograms/ ml), @DRUG$ ( 10 ng/ml ) , and insulin ( 3.7 micrograms/ml or 0.1 IU/ml ) .	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and @DRUG$.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Warfarin: @DRUG$ enhances the effect of @DRUG$.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide , and prednisone with @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
While @DRUG$ Ibogain has similar affinities for kappa opioid and possibly nicotinic acid receptors, @DRUG$ The affinities for NMDA and Sigma-2 receptors, sodium channels and 5-HT transporters are significantly lower than ibogain.	DDI-false
Co-medicines that induce CYP3A4 (e.g. @DRUG$ , @DRUG$ , carbamazepine , rifampin , phenobarbital or St.	DDI-false
Medicines that cause the release of renin : The antihypertensive effect of @DRUG$ and enalapril IV is augmented by antihypertensive agents that cause renin release ( e.g. , @DRUG$ ) .	DDI-effect
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Both @DRUG$ - and 18-MC block @DRUG$-induced and nicotine-induced dopamine release in nucleus accumbens;	DDI-effect
In EM-persons treated with @DRUG$ or @DRUG$ , the AUC of atomoxetine is approximately 6- to 8-fold and Css , max is about 3- to 4-fold greater than atomoxetine alone .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Moreover , additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels , and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, @DRUG$, erythromycin, clarithromycin).	DDI-false
It is structurally distinct from the other currently available @DRUG$ (lovastatin, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with @DRUG$ Or potent diuretics like furosemide.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
The following eight target drug/add drug combinations have been investigated: @DRUG$/@DRUG$.	DDI-false
Clinical implications of @DRUG$ # Interactions with five @DRUG$.	DDI-int
@DRUG$ : Lithium toxicity has been reported in patients receiving @DRUG$ Accompanied by medicines that cause the excretion of sodium, including ACE inhibitors.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Little has been studied of the adverse effects of the exposure of the liver to the interaction of @DRUG$ with its congeners and @DRUG$, coexisting in the contents of alcoholic beverages.	DDI-false
@DRUG$ , such as verapamil , diltiazem and @DRUG$ , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
Non-selective MAO inhibitors including @DRUG$ , @DRUG$ , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents , specifically , @DRUG$ , @DRUG$ , tamoxifen and interferon-alfa .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when administering imatinib @DRUG$ Inhibitors of the CYP3A4 family (e.g. @DRUG$ Itraconazole, erythromycin, clarithromycin).	DDI-advise
@DRUG$ and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ Incorporating coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as: @DRUG$ NSAIDs and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$ , e.g. , guanethidine , @DRUG$ , reserpine .	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-false
@DRUG$ : In some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs , the co-administration of @DRUG$ may result in a further deterioration of renal function .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
The effects of @DRUG$ (RR) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Co-administration of naltrexone with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
@DRUG$     @DRUG$ antagonism	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , @DRUG$ , nitrates , calcium-blocking agents , hydralazine , @DRUG$ and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant administration of these agents with PROLEUKIN may reduce the efficacy of antitumours. @DRUG$ and thus should be avoided . 12 @DRUG$ In PROLEUKIN, hypotension and other antihypertensive agents may be increased.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , @DRUG$ , @DRUG$ , sedatives, sedatives).	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, antiemetics, @DRUG$, @DRUG$).	DDI-false
The effects of concomitant @DRUG$ administration on the steady-state pharmacokinetics of @DRUG$.	DDI-false
Anticoagulants including coumarin derivatives, indandion derivatives and @DRUG$ such as @DRUG$ NSAIDs and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
@DRUG$ , @DRUG$ , phenobarbital, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions including fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant use of these active substances with @DRUG$ The effectiveness of antitumours can be reduced. @DRUG$ Beta-blockers and other antihypertensive agents may increase the hypotension observed with PROLEUKIN.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/phenobarbital.	DDI-false
@DRUG$ and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone with @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
The @DRUG$ They are a family of anxiolytics and @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , @DRUG$/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and quinidine.	DDI-advise
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing transferrin ( 1 microgram/ml ) , @DRUG$ ( 10 ng/ ml ) and @DRUG$ [ 3.7 micrograms/ ml or 0.1 IU/ ml].	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, @DRUG$ and interferon-alfa.	DDI-false
@DRUG$ , lidocaine, phenobarbital, quinidine, theophylline and @DRUG$ The pooled human serum was added at therapeutic concentrations.	DDI-false
@DRUG$ : In some patients with compromised renal function who are being treated with @DRUG$ , the co-administration of enalapril may result in a further deterioration of renal function .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or with a CHOP-like regimen (i.e. cyclophosphamide, doxorubicin, teniposide and prednisone with vincristine plus bleomycin), without @DRUG$ therapy .	DDI-false
@DRUG$ should not be used as a substitute for oral or inhaled @DRUG$.	DDI-false
Although neither @DRUG$ nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
In a clinical pharmacology study, @DRUG$ or @DRUG$ was administered to hypertensive patients receiving VASOTEC.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Therefore, interactions after concomitant use of @DRUG$ ( e.g. , narcotics , @DRUG$ , antiemetics , sedatives , tranquilizers ) .	DDI-false
There is a significant increase in exposure to @DRUG$ when @DRUG$ It is co-administered with ketoconazole ( CYP3A4 inhibitor).	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
Acetaminophen , lidocaine , phenobarbital , quinidine , @DRUG$ , and @DRUG$ were added to pooled human serum at therapeutic concentrations .	DDI-false
Concurrent administration of @DRUG$ (for the treatment of hypotension related to obstetric blocks) and @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-effect
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with xanthine derivatives , @DRUG$ , or @DRUG$ A potential hypokalemic effect of beta2-agonists may be increased.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , glutethimide , @DRUG$ and @DRUG$ The treatment was systematically studied in 16 patients receiving coumarin therapy.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or CHOP-like regimen (i.e., cyclophosphamide, doxorubicin), @DRUG$ , and prednisone with vincristine plus bleomycin) without reception @DRUG$ therapy .	DDI-false
The administration of local anesthetic solutions containing @DRUG$ Patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-effect
Non-selective MAO inhibitors including @DRUG$ , phenelzine sulfate , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension .	DDI-false
Other medicines: medicines such as quinidine, @DRUG$ , @DRUG$ , phenothiazines, antihistamines and tricyclic antidepressants may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Although neither @DRUG$ The proliferation of the prostate epithelium in RPMI1640, which contains transferrin alone, was not influenced by retinyl acetate, they modify the mitogenic effect of @DRUG$ and insulin .	DDI-effect
Therefore, when meclofenamate sodium is given to a patient receiving @DRUG$, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were used together with beta-adrenergic blockers, methyldopa, nitrates, @DRUG$ , hydralacin, prazosin and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Like ibogain ( 40 mg/kg), @DRUG$ 40 mg/kg decreases intravenous self-administration of morphine and cocaine and oral self-administration of ethanol and @DRUG$ in rats ;	DDI-false
- Non-selective MAO inhibitors including tranylcypromin sulfate, phenylzinsulfate and @DRUG$ HC1 : Concomitant use of @DRUG$ Non-selective MAO inhibitors can lead to hypertension.	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Concurrent use with @DRUG$ or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of @DRUG$.	DDI-mechanism
only @DRUG$ enhances @DRUG$-induced increases in accumbal dopamine.	DDI-effect
The @DRUG$ Study participants with 1200 mg/day azithromycin ( n = 7 ) ( subsequently changed to 600 mg/day [ n = 5 ]) for days 8 to 21 of a 21-day course of 100 mg, five times/day @DRUG$.	DDI-false
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when using Gleevec with CYP3A4 inhibitors (e.g. @DRUG$ , itraconazole , @DRUG$ , clarithromycin ) .	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin , @DRUG$ , and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ The treatment can be either by stopping the diuretic or by increasing the intake of salt before starting treatment with @DRUG$ or enalaprilat .	DDI-false
@DRUG$ had a similar effect in the presence of @DRUG$.	DDI-false
Other medicines: medicines such as quinidine, disopyramide, procainamide, phenothiazine, @DRUG$ , and @DRUG$ It may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ , but not @DRUG$ , lowers the heart rate at high doses.	DDI-false
• Lack of an effect of @DRUG$ on the disposition of zidovudine and @DRUG$ In HIV-infected patients.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Coadministration of @DRUG$ with 40 mg SULAR tablets in epileptic patients lowered the @DRUG$ Plasma concentrations up to undetectable concentrations.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
@DRUG$: Concurrent administration of aspirin may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-false
The application of local anaesthetic solutions that @DRUG$ - Nonepinephrine in patients who: @DRUG$ , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-effect
The effects of @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced movement and behavioural changes in mice.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of amphotericin B can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
The bioavailability of the capsule formulation of @DRUG$ was not affected when administered 5 minutes following an @DRUG$.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, @DRUG$).	DDI-false
@DRUG$ is the first @DRUG$ to be approved for clinical use, and has been studied extensively in humans since 1986.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$ , specifically , dacarbazine , cis-platinum , @DRUG$ and interferon-alfa .	DDI-false
Potassium-sparing diuretics ( e.g. , spironolactone , @DRUG$ , or amiloride ) , @DRUG$ supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , @DRUG$ , chloralhydrate and @DRUG$ The treatment was systematically studied in 16 patients receiving coumarin therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG$, @DRUG$ or St.	DDI-false
@DRUG$ Including coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as non-steroidal anti-inflammatory drugs ( @DRUG$ ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, @DRUG$, reserpine.	DDI-false
@DRUG$ has been shown to be antagonistic to @DRUG$, including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when using Gleevec with CYP3A4 inhibitors (e.g. @DRUG$ , itraconazole, erythromycin, @DRUG$ ) .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , @DRUG$ , @DRUG$ Erythromycin, clarithromycin, erythromycin, erythromycin, erythromycin.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , @DRUG$ chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate, asparaginase) effects with @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Concomitant @DRUG$ , doxorubicin , vincristine , and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Other drugs : Drugs like @DRUG$ , disopyramide, procainamide, phenothiazine, @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Other Drugs : Drugs such as quinidine , disopyramide , procainamide , @DRUG$ , antihistamines , and @DRUG$ It may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/@DRUG$.	DDI-false
@DRUG$ Potassium supplements (e.g. spironolactone, triamterene or amiloride), potassium supplements or salt substitutes containing @DRUG$ may lead to a significant increase in serum potassium.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
@DRUG$ and @DRUG$ similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Both ibogaine and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens , but only @DRUG$ Elevates extracellular serotonin levels in the nucleus accumbens.	DDI-false
@DRUG$ It can cause acidic drugs such as phenytoin or @DRUG$ From their binding sites.	DDI-mechanism
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : @DRUG$ In patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, the use should be carried out with extreme caution as the effect of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF .	DDI-effect
there was no significant change in prothrombin test results during the trials of @DRUG$ and @DRUG$.	DDI-false
Moreover, additional interaction studies with @DRUG$ and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Both @DRUG$ and 18-MC decrease extracellular levels of dopamine in the nucleus accumbens , but only @DRUG$ Elevates extracellular serotonin levels in the nucleus accumbens.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, methyldopa, @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Simultaneous cyclophosphamide, doxorubicin, @DRUG$ , and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Simultaneous cyclophosphamide, doxorubicin, @DRUG$ , and prednisone chemotherapy plus @DRUG$ Treatment in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma.	DDI-false
Although drug interaction studies have not been conducted, corticosteroids or @DRUG$ The treatment of relapses for up to 28 days was administered to patients ( N=180 ) at @DRUG$.	DDI-false
@DRUG$/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors , 18-MC has much lower affinities than @DRUG$ For NMDA and Sigma-2 receptors, sodium channels and the 5-HT transporter.	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the @DRUG$ response to apomorphine in the treatment of poisoning .	DDI-false
@DRUG$ - prior ingestion of @DRUG$ may decrease the emetic response to apomorphine in the treatment of poisoning .	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, rifampin, @DRUG$ or St.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Concomitant @DRUG$ , @DRUG$ , vincristine , and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Potassium-sparing diuretics (e.g. spironolactone, triamterene or @DRUG$ ) , @DRUG$ supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and @DRUG$.	DDI-false
@DRUG$ ♪ Don't affect the serum ♪ @DRUG$ levels .	DDI-false
Other, no impact on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and fluvastatin .	DDI-false
Other Cardiovascular Agents : Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ , calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and @DRUG$ - Non-steroidal anti-inflammatory medicines ( @DRUG$ ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Other Drugs : Drugs such as quinidine , @DRUG$ Procainamide, phenothiazine, antihistamines and @DRUG$ It may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-false
The effects of DCG-IV and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice .	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , @DRUG$ , @DRUG$.	DDI-false
Azithromycin had no significant effect on Cmax and AUC of @DRUG$ However, although it significantly reduced the @DRUG$ Tmax increased by 44% and intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
There is a significant increase in exposure to imatinib if: @DRUG$ is coadministered with @DRUG$ ( CYP3A4 inhibitor ) .	DDI-mechanism
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-advise
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Concomitant cyclophosphamide , @DRUG$ , vincristine , and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma.	DDI-false
• Myocardial infarction, myocardial infarction, myocardial infarction, ventricular hypokinesia and severe rhabdomyolysis appear in patients who: @DRUG$ and @DRUG$ concurrently .	DDI-effect
It is structurally distinct from the other currently available @DRUG$ (@DRUG$, simvastatin, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
In addition, the mechanisms that can be similar to the development of dependency may be similar for @DRUG$ and @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these polyene antibiotics showed differential effects on cells;	DDI-false
CYP2D6 inhibitors - @DRUG$ The metabolism is primarily via the CYP2D6 route to @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and @DRUG$ Prostate epithelium proliferation can be controlled by dose-dependent changes in insulin and EGF activity.	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents : @DRUG$ ug and Enalapril IV together with @DRUG$ , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
The concomitant use of naltrexone with @DRUG$ The result was a 25% increase in AUC and a 33% increase in Cmax of @DRUG$.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, @DRUG$ - Nitrates, calcium blockers, @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma ( HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e. cyclophosphamide), @DRUG$ , @DRUG$ , and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
@DRUG$ The Cmax and AUC had no significant effects on the Cmax and AUC. @DRUG$ , although it significantly decreased the zidovudine tmax by 44 % and increased the intracellular exposure to phosphorylated zidovudine by 110 % .	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , @DRUG$ and @DRUG$ , on the above behavioral changes induced by PCP were found .	DDI-false
@DRUG$ It was also used at the same time as @DRUG$ without evidence of clinically significant adverse reactions .	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , @DRUG$ , @DRUG$ , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$ FORADIL should be used in patients with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
Acid-catalyzed ethanolysis of @DRUG$ in anhydrous and aqueous @DRUG$ solutions .	DDI-mechanism
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ , @DRUG$ ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
unlike @DRUG$ , @DRUG$ "Does not affect the reaction to a non-drug booster (water).	DDI-false
and ( ii ) the effects of @DRUG$ were more efficiently inhibited by added cholesterol , the major membrane sterol in human cells , whereas the effects of @DRUG$ The main membrane sterol in the yeast was more efficiently affected by ergosterol.	DDI-false
The intensity , uniformity and time course of @DRUG$ interference by phenobarbital , secobarbital , glutethimide , chloral hydrate and @DRUG$ The treatment was systematically studied in 16 patients receiving coumarin therapy.	DDI-false
Careful observation is required when @DRUG$ is administered concurrently with @DRUG$.	DDI-advise
The monoamine oxidase inhibitory effects of @DRUG$ This should be taken into account if another medicine is prescribed after @DRUG$.	DDI-false
Concomitant use with @DRUG$s may result in the reduced absorption of @DRUG$.	DDI-false
The effects of @DRUG$ From and L-CCG-1 after phencyclidine (@DRUG$)-induced movement and behavioural changes in mice.	DDI-false
Also, phenobarbital, @DRUG$ , and @DRUG$ , both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum .	DDI-false
@DRUG$ including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF.	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
In addition to this pharmacological interaction , this report describes a novel chemical reaction between @DRUG$ ( a @DRUG$ ) and ethanol under acidic conditions similar to those found in vivo , resulting in a 3-ethoxylated product .	DDI-false
@DRUG$/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as @DRUG$ ( NSAIDs ) , and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
The effect of the blood pressure of @DRUG$ In chronic renal failure patients, the @DRUG$ As in patients who did not receive any other antihypertensive therapy.	DDI-effect
Based on the results of these studies, it is concluded that: @DRUG$ It can be safely used together with both. @DRUG$ and dideoxyinosine .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, sedatives, @DRUG$).	DDI-false
acetaminophen/@DRUG$, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drug/Laboratory Test Interactions @DRUG$, including @DRUG$, are known to occasionally induce a positive direct Coombs test.	DDI-false
Further , no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In addition , we have shown that @DRUG$ It is a useful pharmacological tool to investigate the @DRUG$-mediated reactions of megakaryocytes.	DDI-false
@DRUG$ : @DRUG$ enhances the effect of warfarin .	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
@DRUG$ , lidocaine , @DRUG$ , quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-mechanism
and (ii) the effects of @DRUG$ were more efficiently inhibited by added cholesterol, the major membrane sterol in human cells, whereas the effects of @DRUG$ were more efficiently inhibited by ergosterol, the major membrane sterol in yeast.	DDI-false
Acetaminophene/theophylline, lidocaine/chinidine, @DRUG$/@DRUG$ , phenobarbital/ valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Coingestion of @DRUG$ With theophylline, phenobarbital with acetaminophene and valproic acid with @DRUG$ At high to toxic concentrations, binding of the target medication is reduced.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and @DRUG$ , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-effect
@DRUG$ (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The effects of @DRUG$ and L-CCG-1 upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown .	DDI-mechanism
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Clinical implications of @DRUG$ interactions with five @DRUG$.	DDI-int
Other Cardiovascular Agents : @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ , calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , @DRUG$ , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
@DRUG$: Concurrent administration of @DRUG$ may lower meclofenamate sodium plasma levels, possibly by competing for protein-binding sites.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ ) or hepatotoxic (e.g. @DRUG$ Asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Corticosteroids , @DRUG$ and Diuretics : Concomitant treatment with xanthine derivatives , steroids , or @DRUG$ A potential hypokalemic effect of beta2-agonists may be increased.	DDI-false
There is a significant increase in exposure to @DRUG$ when @DRUG$ is coadministered with ketoconazole (CYP3A4 inhibitor).	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , @DRUG$ ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , @DRUG$ Effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and @DRUG$ CHOP chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ Incorporating tranylcypromin sulfate, @DRUG$ , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
• Non-selective MAO inhibitors including @DRUG$ , Phenelzinsulfate, and @DRUG$ HC1 : Concurrent use of L-tyrosine and non-selective MAO inhibitors may lead to high blood pressure.	DDI-false
Other drugs : Drugs like @DRUG$ , disopyramide, procainamide, phenothiazine, antihistamines and @DRUG$ It may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Both @DRUG$ and @DRUG$ morphin-induced and nicotine-induced dopamine release in the nucleus of accumben;	DDI-false
The immediate release, but not the Coat Core formulation of @DRUG$ increased plasma @DRUG$ concentrations by about 20 % .	DDI-mechanism
Higher concentrations of @DRUG$ ( 10(-8 ) - 10(-6 ) M ) or @DRUG$ ( 3 X 10(8) - 10(7) M ) increase the mitogenic activity of the EGF.	DDI-false
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , phenytoin , @DRUG$ , @DRUG$ , phenobarbital or St.	DDI-false
However, reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Concomitant administration of @DRUG$ The AUC for @DRUG$ has been doubled.	DDI-mechanism
@DRUG$, such as verapamil, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
While @DRUG$ and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , @DRUG$ , carbamazepine, rifampin, @DRUG$ or St.	DDI-false
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with xanthine derivatives , steroids , or @DRUG$ A possible hypocalemic effect of @DRUG$	DDI-effect
Acetaminophen, @DRUG$, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Acetaminophen , @DRUG$ , phenobarbital , @DRUG$ Theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
While @DRUG$ and @DRUG$ 18-MC has much lower affinities than ibogain for NMDA and Sigma-2 receptors, sodium channels and 5-HT transporters.	DDI-false
Apomorphine - before taking @DRUG$ may decrease the @DRUG$ Reaction to apomorphine in the treatment of poisoning.	DDI-false
@DRUG$ should be administered with caution to patients receiving Antabuse ( @DRUG$ , Wyeth-Ayerst Laboratories ) .	DDI-advise
Delayed Adverse Reactions to @DRUG$ : A review of the literature revealed that 12.6 % ( range 11 - 28 % ) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered @DRUG$ There were acute, atypical side effects.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , @DRUG$ , @DRUG$ , clarithromycin ) .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, @DRUG$).	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat may be due to discontinuation of @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
The effects of @DRUG$ The @DRUG$-induced hyperlocomotion was very strong and completely depressed.	DDI-effect
@DRUG$ FORADIL should be used with extreme caution in patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, as the effect of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
Because @DRUG$ is metabolized by CYP2C9 and CYP3A4, patients who require anticoagulation should receive low-molecular weight or standard @DRUG$.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors , e.g. , paroxetine , @DRUG$ , and @DRUG$.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Among the @DRUG$, many, like @DRUG$, cannot be used clinically because they are toxic;	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Administering @DRUG$ together with @DRUG$ InsP(3)-induced reactions ( both Ca(2 + ) and current reactions ) in a dose-dependent manner.	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by @DRUG$ , secobarbital , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
Acetaminophen, @DRUG$, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
♪ Drugs that can change ♪ @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , @DRUG$ ,,,,,,,,,,,	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with @DRUG$ or potent diuretics such as furosemide.	DDI-effect
Other Cardiovascular Agents : Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.	DDI-mechanism
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, @DRUG$, sedatives, tranquilizers).	DDI-false
Chloramphenicol has been shown to be antagonistic to @DRUG$, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-false
Two groups ( SH/DA ; SH/FA ) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol , @DRUG$ , higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages ;	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent diuretics such as @DRUG$.	DDI-effect
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with @DRUG$.	DDI-effect
Therefore, when @DRUG$ is given to a patient receiving @DRUG$, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with @DRUG$ plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, @DRUG$.	DDI-false
Coingestion of acetaminophen with @DRUG$ , @DRUG$ With acetaminophene and valproic acid with phenobarbital at high to toxic concentrations, binding of the target medication is reduced.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and @DRUG$/phenobarbital.	DDI-false
Moreover , additional interaction studies with @DRUG$ and @DRUG$ Administration to a patient population that received chronic digoxin did not differ in the extent of the bioavailability of digoxin compared to control data.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , @DRUG$ , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
Both @DRUG$ and @DRUG$ block morphine-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Lack of an effect of @DRUG$ on the disposition of zidovudine and @DRUG$ in HIV-infected patients.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or CHOP-like regimen (i.e., cyclophosphamide, doxorubicin), @DRUG$ , and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent @DRUG$ For example, furosemide.	DDI-false
Both @DRUG$ and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens , but only ibogaine increases extracellular levels of serotonin in the nucleus accumbens .	DDI-false
Concomitant @DRUG$, doxorubicin, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Similarly dialyzed were phenobarbital , @DRUG$ , and theophylline , both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum .	DDI-false
The possibility of hypotensive effects with @DRUG$ Treatment with enalaprilat may occur either by stopping the diuretic or by increasing the intake of salt before starting treatment with @DRUG$ or enalaprilat .	DDI-false
@DRUG$ should not be used as a substitute for oral or inhaled @DRUG$.	DDI-false
The @DRUG$ are a family of anxiolytic and @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients with acamprosate concomitantly with @DRUG$ , hypnotics and @DRUG$ The use of placebo with these concomitant medications was similar to that of volunteers (including benzodiazepines), or non-opioid analgesics.	DDI-false
A inhibition of coagulation inhibition was observed during the use of @DRUG$ , secobarbital and @DRUG$ ;	DDI-false
The pharmacokinetics of naltrexone and its major metabolite @DRUG$ were unaffected following co-administration with @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Acetaminophen, @DRUG$, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of @DRUG$ , increased @DRUG$ Oral dose clearance was reduced by 3.8-fold, significantly reducing the mean cmax and AUC(0-8) (p 0.05).	DDI-false
@DRUG$ 150 mg twice daily did not interact significantly with @DRUG$ (AUC was decreased by 15-20 %).	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions including fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant use of these active substances with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , @DRUG$ , prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
The zidovudine study dosed subjects with 1200 mg/day of @DRUG$ ( n = 7 ) ( later modified to 600 mg/day [ n = 5 ] ) for days 8 to 21 of a 21-day rate of 100 mg, five times/day of @DRUG$.	DDI-false
Other concomitant therapies : In clinical studies, the safety profile in patients with acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ ( including @DRUG$ ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Coingestion of @DRUG$ with theophylline , @DRUG$ With acetaminophene and valproic acid with phenobarbital at high to toxic concentrations, binding of the target medication is reduced.	DDI-false
Like @DRUG$ ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ nicotine in rats;	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Acetaminophene/theophylline, lidocaine/chinidine, phenobarbital/acetaminophene, @DRUG$/@DRUG$ , quinidine/lidocaine, theophylline/acetaminophene and valproic acid/phenobarbital.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Dexamethasone and retinyl acetate similarly inhibit and stimulate @DRUG$- or @DRUG$-induced proliferation of prostatic epithelium .	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, fluoxetine, and @DRUG$.	DDI-advise
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
The effects of DCG-IV and @DRUG$ upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The use of acetaminophene with acetaminophene @DRUG$ , phenobarbital with acetaminophene and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Lithium : @DRUG$ Toxicity has been reported in patients receiving lithium concomitantly with medicinal products that cause sodium excretion, including @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents: @DRUG$ and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ including tranylcypromine sulfate , phenelzine sulfate , and @DRUG$ HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by @DRUG$ , secobarbital , @DRUG$ , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
@DRUG$ and methaqualone interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The effects of @DRUG$ and @DRUG$ upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , @DRUG$ Erythromycin, clarithromycin, erythromycin, erythromycin, erythromycin.	DDI-advise
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In addition, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels , and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ Relative to the control data.	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin) is myelotoxic (e.g. @DRUG$ chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Co-medicines that induce CYP3A4 (e.g. dexamethasone, phenytoin, @DRUG$ , rifampin , @DRUG$ or St.	DDI-false
In a clinical pharmacology study , @DRUG$ Sulindac was given to hypertensive patients receiving @DRUG$.	DDI-false
@DRUG$ and @DRUG$ should not be administered to patients receiving coumarin drugs .	DDI-false
Like ibogaine ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of morphine and @DRUG$ The oral self-administration of ethanol and @DRUG$ in rats ;	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Aspirin : Simultaneous use of @DRUG$ may lower @DRUG$ Plasma levels, possibly through competition for protein-binding sites.	DDI-mechanism
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ and @DRUG$ : FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
In a clinical pharmacology study, @DRUG$ or @DRUG$ was administered to hypertensive patients receiving VASOTEC .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
♪ Drugs that can change ♪ @DRUG$ Plasma concentrations Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when gleevec is administered with CYP3A4 inhibitors (e.g. ketoconazole, @DRUG$ , erythromycin , clarithromycin ) .	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/Phenobarbital.	DDI-false
In addition, additional interaction studies with niacin and propranolol have not shown any effects on fluvastatin plasma levels and use in a patient population that is chronically @DRUG$ This study showed no difference in the extent of bioavailability of @DRUG$ Relative to the control data.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
The results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume @DRUG$ and @DRUG$ Regularly.	DDI-mechanism
Five days of @DRUG$ treatment did not significantly affect steady-state pharmacokinetic variables of @DRUG$ compared with placebo ;	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
@DRUG$ including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Hypotension : Patients on Diuretic Therapy : Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or enalaprilat .	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/@DRUG$.	DDI-false
Further, no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and @DRUG$.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, @DRUG$, tranquilizers).	DDI-false
However, @DRUG$ stimulated, but did not significantly inhibit, proliferation in the presence of @DRUG$.	DDI-effect
Acetaminophen, lidocaine, @DRUG$, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, sedatives, @DRUG$).	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
Coadministration of phenytoin with 40 mg @DRUG$ tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
Other Drugs : Drugs such as @DRUG$ , disopyramide , @DRUG$ , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with @DRUG$ , methyldopa, nitrates, calcium blockers, hydralacin, prazosin and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Barbiturates and @DRUG$ should not be administered to patients receiving @DRUG$.	DDI-advise
Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both @DRUG$ and @DRUG$.	DDI-false
@DRUG$ should be administered with caution to patients receiving Antabuse (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-advise
The intensity, uniformity and time course of @DRUG$ - disorders caused by phenobarbital, @DRUG$ , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a benzodiazepine) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-mechanism
It differs structurally from the other HMGCoA reductase inhibitors currently available ( @DRUG$ , @DRUG$ , and pravastatin ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	DDI-false
The concomitant intake of @DRUG$ and @DRUG$ does not affect the pharmacokinetics of either alcohol or acamprosate.	DDI-false
The hypoglycaemic effect of @DRUG$ has been reported to increase when @DRUG$ It is given at the same time.	DDI-effect
It differs structurally from the other currently available @DRUG$ ( lovastatin , @DRUG$ , and pravastatin), resulting in unique biopharmaceutical properties compared to the other active substances of this class.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Other medicines: medicines such as quinidine, @DRUG$ , procainamide , @DRUG$ , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both zidovudine and @DRUG$.	DDI-false
Although this effect was noted even when @DRUG$ The dose was given 4 hours before @DRUG$ , this regimen did not result in diminished efficacy .	DDI-effect
@DRUG$, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
acetaminophen/@DRUG$, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
@DRUG$ It had no significant effects on the Cmax and AUC of zidovudine, although it significantly reduced the Cmax and AUC of zidovudine. @DRUG$ Tmax increased by 44% and intracellular exposure to phosphorylated zidovudine by 110%.	DDI-mechanism
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., @DRUG$, analgesics, antiemetics, sedatives, tranquilizers).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
There is a significant increase in exposure to @DRUG$ when Gleevec is coadministered with @DRUG$ ( CYP3A4 inhibitor ) .	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine , the AUC of @DRUG$ The maximum is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Gleevec increases plasma concentrations of other CYP3A4 metabolised medicinal products (e.g. triazolo@DRUG$, dihydropyridine calcium channel blockers, certain @DRUG$ , etc . ) .	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors , e.g. , paroxetine , @DRUG$ ==References====External links==	DDI-advise
@DRUG$ , methylxanthine and diuretics: concomitant treatment with xanthine derivatives, steroids or @DRUG$ A potential hypokalemic effect of beta2-agonists may be increased.	DDI-false
How ibogain ( 40 mg/kg ) reduces intravenous self-injection of 18-MC ( 40 mg/kg ) @DRUG$ • Cocaine and oral self-administration of ethanol and @DRUG$ in rats ;	DDI-false
Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of @DRUG$, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Dosage adjustment of @DRUG$ It may be necessary when co-administered with CYP2D6 inhibitors such as paroxetine, fluoxetine and @DRUG$.	DDI-advise
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Other concomitant therapies : In clinical trials, the safety profile in patients with acamprosate concomitantly with @DRUG$ Hypnotics and sedatives (including @DRUG$ ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
The effect of @DRUG$ The patient's warfarin requirement seemed to be a maximum of 5 to 7 days after the onset of rifampin and extended a similar period of time after the onset of rifampin. @DRUG$ withdrawal .	DDI-false
Quetiapine fumarate ( ' @DRUG$ ==References====External links== @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia .	DDI-false
The effect of @DRUG$ on the @DRUG$ The need of our patient seemed to be a maximum of 5 to 7 days after the initiation of rifampin and extended a similar time after the withdrawal of rifampin.	DDI-effect
Corticosteroids , @DRUG$ and Diuretics : Concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of   @DRUG$	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Medicines that cause the release of renin : The antihypertensive effect of @DRUG$ and @DRUG$ The infusion is enhanced by antihypertensive agents that cause the release of renins (e.g. diuretics).	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$ , although it significantly decreased the zidovudine tmax by 44 % and increased the intracellular exposure to phosphorylated @DRUG$ - 110%.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain @DRUG$, etc.).	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, @DRUG$).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Monoamine oxidase inhibitors and tricyclic antidepressants : @DRUG$ should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-advise
Fenfluramine may increase slightly the effect of @DRUG$, e.g., @DRUG$, methyldopa, reserpine.	DDI-false
@DRUG$ does not affect serum @DRUG$ levels.	DDI-false
@DRUG$ may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, reserpine.	DDI-effect
• Corticosteroids, methylxanthine and diuretics: concomitant treatment with @DRUG$ Steroids or diuretics may potentiate a possible hypocalemic effect @DRUG$	DDI-effect
@DRUG$ It has been shown that it is an antagonistic @DRUG$ , including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
The possibility of hypotensive effects with enalapril or @DRUG$ , can be minimized by either @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat .	DDI-effect
Potassium-sparing diuretics ( e.g. , @DRUG$ , triamterene , or @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
Therefore , when @DRUG$ It is given to a patient who: @DRUG$ The dose of warfarin should be reduced to prevent excessive prolongation of prothrombin time.	DDI-advise
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when administering imatinib @DRUG$ with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , erythromycin , @DRUG$ ) .	DDI-advise
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with @DRUG$ may increase toxicity in these organ systems .	DDI-effect
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , @DRUG$ ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
The @DRUG$ You are a family of @DRUG$ And hypnotic drugs.	DDI-false
Co-medicines that induce CYP3A4 (e.g. @DRUG$ , phenytoin , carbamazepine , rifampin , @DRUG$ or St.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, @DRUG$, clarithromycin).	DDI-false
@DRUG$, an anionic-binding resin, has a considerable effect in lowering the rate and extent of @DRUG$ bioavailability.	DDI-mechanism
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$ , in particular, dacarbazine, @DRUG$ , tamoxifen and interferon alpha.	DDI-false
The effects of @DRUG$ In combination with Fura-2 microfluorometry, the (RR)-induced reactions of inositol 1.4.5-trisphosphate (@DRUG$) on megacaryocytes of the rat's bone marrow were investigated using patch-clamp full-cell recording technique.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide, and prednisone with vincristine plus bleomycin) without treatment @DRUG$ therapy .	DDI-false
unlike @DRUG$, @DRUG$ does not affect responding for a nondrug reinforcer (water).	DDI-false
This study demonstrated that the potent cytochrome P450 enzyme-inducer @DRUG$ did indeed have a marked effect on the metabolism of @DRUG$, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder.	DDI-mechanism
Medicines that may alter the plasma concentration of imatinib Drugs that may increase the plasma concentration of imatinib @DRUG$ Plasma concentrations: Caution should be exercised when gleevec is administered with inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, @DRUG$ , clarithromycin ) .	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-@DRUG$ , @DRUG$ , certain HMG-CoA reductase inhibitors, etc.).	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
@DRUG$ ('Seroquel') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine , the AUC of atomoxetine is approximately 6- to 8-fold and Css , max is about 3- to 4-fold greater than @DRUG$ alone .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Careful observation is required when @DRUG$ is administered concurrently with @DRUG$.	DDI-advise
In addition to this pharmacological interaction, this report describes a novel chemical reaction between temazepam (a @DRUG$) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
Little has been said about the adverse effects of liver exposure to the interaction of @DRUG$ with its congeners and @DRUG$ , coexisting in the contents of alcoholic beverages .	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by @DRUG$ , secobarbital , glutethimide , @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
Slow-channel calcium blockers, such as @DRUG$, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$ , tricyclic antidepressants or @DRUG$ may produce severe , prolonged hypotension or hypertension .	DDI-false
It is concluded that @DRUG$ and @DRUG$ When monitoring the prothrombin test during oral anticoagulant therapy, administration can be done without additional caution.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/@DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide , and @DRUG$ with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Both ibogaine and 18-MC block @DRUG$-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-false
Acetaminophen/theophylline, @DRUG$/chinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , @DRUG$ , nitrates , @DRUG$ , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
The data suggest that: @DRUG$ It has a narrower range of effects and will have a much larger therapeutic index than @DRUG$.	DDI-false
The pharmacokinetics of @DRUG$ The main metabolite 6-beta-naltrexol and its main metabolite were not affected after co-administration with @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Apomorphine - before taking @DRUG$ The emetic reaction to @DRUG$ In the treatment of poisoning.	DDI-effect
The effects of ruthenium red ( @DRUG$ 1.4.5-trisphosphate (@DRUG$)-induced reactions have been studied on megacaryocytes of the rat's bone marrow with patch-clamp whole cell recording technique in combination with Fura-2 microfluorometry.	DDI-false
Hypotension : Patients on Diuretic Therapy : Patients on diuretics and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or @DRUG$.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as @DRUG$ ( NSAIDs ) , and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
The benzodiazepines are a family of @DRUG$ and @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Acetaminophen/theophylline, @DRUG$/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , @DRUG$ , methyldopa , @DRUG$.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were used together with beta-adrenergic blockers, methyldopa, nitrates, @DRUG$ , hydralazine , @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
In EM individuals treated with paroxetine or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( NSAIDs ) , and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or @DRUG$ ) , potassium supplements , or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
Non-selective MAO inhibitors including @DRUG$ , Phenelzinsulfate, and Pargylin HC1 : Simultaneous use of @DRUG$ Non-selective MAO inhibitors can lead to hypertension.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Lithium : @DRUG$ toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium , including ACE inhibitors .	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Based on the results of these studies, it is concluded that azithromycin can be safely administered with both. @DRUG$ and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and antineoplastic agents, especially dacarbazine. @DRUG$ , @DRUG$ and interferon-alfa .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/@DRUG$.	DDI-false
These results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and @DRUG$.	DDI-false
Therefore, when @DRUG$ is given to a patient receiving warfarin, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
Both @DRUG$ - and 18-MC blockmorphine-induced and @DRUG$-induced dopamine release in nucleus accumbens;	DDI-effect
Nephrotoxicity following concomitant administration of @DRUG$ - with aminoglycoside antibiotics or potent @DRUG$ such as furosemide .	DDI-effect
* Exacerbation or the first appearance of a series of autoimmune and inflammatory disorders following concomitant administration of @DRUG$ and @DRUG$ , including crescentic IgA glomerulonephritis, oculo-bulbar myasthenia gravis, inflammatory arthritis, thyroid inflammation, bullous pemphigoid, and Stevens-Johnson syndrome.	DDI-effect
Like @DRUG$ ( 40 mg/ kg ), @DRUG$ 40 mg/kg) decreases intravenous self-administration of morphine and cocaine and oral self-administration of ethanol and nicotine in rats;	DDI-false
@DRUG$ Meclofenamate sodium increases the effect of @DRUG$.	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window ( e.g. , cyclosporine or @DRUG$ ) .	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Hypotension: Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or @DRUG$.	DDI-false
Acute symptoms should be treated with a short-acting, inhaled  @DRUG$ such as @DRUG$ (the physician should provide the patient with such medication and instruct the patient in how it should be used).	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
apomorphine - prior ingestion of diphenidol may decrease the @DRUG$ response to @DRUG$ in the treatment of poisoning.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
Lack of an effect of @DRUG$ on the disposition of @DRUG$ and dideoxyinosine in HIV-infected patients.	DDI-false
• Non-selective MAO inhibitors including tranylcypromin sulfate, phenylzinsulfate and pargylin HC1: Concomitant use of @DRUG$ and non-selective @DRUG$ - May cause high blood pressure.	DDI-effect
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, co-administration of these active substances with PROLEUKIN may reduce the efficacy of PROLEUKIN against the tumour and should therefore be avoided. @DRUG$ Hypotension can be amplified with @DRUG$.	DDI-effect
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ Plasma concentrations: Caution should be exercised when gleevec is administered with inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, erythromycin, @DRUG$ ) .	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$ FORADIL should be used with extreme caution in patients who are treated with: @DRUG$ Or tricyclic antidepressants, because the effect of formoterol on the cardiovascular system can be enhanced by these active substances.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without reception @DRUG$ therapy .	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ and @DRUG$.	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/@DRUG$ Theophylline/acetaminophene and valproic acid/phenobarbital.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$: @DRUG$ enhances the effect of warfarin.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide, and prednisone with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
Concomitant administration of other @DRUG$ may potentiate the undesirable effects of @DRUG$.	DDI-effect
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of @DRUG$ Gleevec increased oral dose clearance by 3.8-fold, significantly reducing mean cmax and AUC (0-8) (p 0.05).	DDI-mechanism
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin), myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate), @DRUG$ ) effects with @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
Therefore , when @DRUG$ The dose is given to a patient receiving warfarin. @DRUG$ To prevent excessive prolongation of prothrombin time, the dose should be reduced.	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone , they modify the mitogenic effect of @DRUG$ and @DRUG$.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Both @DRUG$ and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only ibogaine increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
Coingestion of @DRUG$ with theophylline , phenobarbital with acetaminophen , and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Both ibogaine and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
The conversion of @DRUG$ to @DRUG$ The aldehyde oxidase is catalysed.	DDI-false
These results suggest that both dexamethasone and retinyl acetate , and possibly other @DRUG$ Prostate epithelium proliferation can be regulated by dose-dependent changes in insulin and @DRUG$ activity.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering @DRUG$ ketoconazole, itraconazole, @DRUG$ ,,,,,,,,,,,	DDI-advise
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-benzodiazepines , dihydropyridine calcium channel blockers , certain @DRUG$ ..............................................................................................................................................................................................................................................................................................................................................................................	DDI-mechanism
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ Beta-blockers and other antihypertensive agents may increase the hypotension observed with PROLEUKIN.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent @DRUG$ such as @DRUG$.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on atenolol than in patients on no other @DRUG$ therapy .	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of zidovudine , although it significantly decreased the @DRUG$ tmax by 44 % and increased the intracellular exposure to phosphorylated @DRUG$ by 110 % .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The effects of @DRUG$ were very strong and completely depressed the @DRUG$-induced hyperlocomotion.	DDI-effect
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Acetaminophen, lidocaine, phenobarbital, quinidine, @DRUG$, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
The coingestion of acetaminophen with theophylline, @DRUG$ with @DRUG$ , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-effect
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of enalapril may result in a further deterioration of renal function.	DDI-false
Therefore, the combined use of @DRUG$ with @DRUG$ should generally be avoided.	DDI-advise
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
@DRUG$ has been shown to be antagonistic to beta-lactam antibiotics, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
These results suggest that both dexamethasone and @DRUG$ The proliferation of prostatic epithelium, and possibly other glucocorticoids and retinoids, may be controlled by dose-dependent changes in insulin and @DRUG$ activity.	DDI-effect
Co-medicines that induce CYP3A4 (e.g. dexamethasone, @DRUG$ , carbamazepine , @DRUG$ , phenobarbital or St.	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , @DRUG$ , antiemetics, sedatives, @DRUG$ ) .	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant administration of these active substances with PROLEUKIN may reduce the efficacy of PROLEUKIN against the tumour and should therefore be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
- Non-selective MAO inhibitors including tranylcypromin sulfate, @DRUG$ , and pargyline HC1 : Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension .	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Also, phenobarbital, quinidine, and @DRUG$ , both alone at therapeutic concentrations in serum and with @DRUG$ At three different serum concentrations.	DDI-false
==References====External links== @DRUG$ , @DRUG$ In vitro inhibition of platelet activation and decrease of platelet adhesion intravascular.	DDI-false
Withdrawal of @DRUG$ decreased the @DRUG$ - 50 % requirement.	DDI-mechanism
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Other cardiovascular agents: @DRUG$ ug and Enalapril IV were used together with beta-adrenergic blockers, @DRUG$ Nitrates, calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Corticosteroids , Methylxanthines and @DRUG$ Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a possible hypokalemic effect @DRUG$	DDI-false
Coingestion of @DRUG$ with theophylline , phenobarbital with @DRUG$ Valproic acid with phenobarbital in high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$: Meclofenamate sodium enhances the effect of @DRUG$.	DDI-false
Anticoagulant inhibition was observed during the administration of phenobarbital, @DRUG$ and @DRUG$;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were associated with beta-adrenergic blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$ , @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
acetaminophen/theophylline , @DRUG$/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Potassium-sparing diuretics ( e.g. , spironolactone , @DRUG$ , or amiloride ) , potassium supplements , or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Acetaminophen , lidocaine , phenobarbital , @DRUG$ , @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
The effects of DCG-IV and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
In a clinical pharmacology study, indomethacin or @DRUG$ was administered to hypertensive patients receiving @DRUG$.	DDI-false
@DRUG$ including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( NSAIDs ) , and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Although drug interaction studies have not been conducted, it has been established that: @DRUG$ or ACTH treatment of relapses for periods of up to 28 days has been administered to patients ( N=180 ) receiving @DRUG$.	DDI-false
Other Cardiovascular Agents : @DRUG$ and @DRUG$ Co-administered with beta-adrenergic blockers, methyldopa, nitrates, calcium blockers, hydralacin, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
@DRUG$     @DRUG$ antagonism	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Two groups ( SH/DA ; SH/FA ) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol , methanol , higher @DRUG$ and @DRUG$ — in the same proportions as in the most frequently distilled and fermented alcoholic beverages;	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The effects of @DRUG$ ( RR ) on @DRUG$ The reactions induced with InsP(3) were studied in combination with Fura-2 microfluorometry on megacaryocytes of the rat's bone marrow with the patch-clamp whole cell recording technique.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( @DRUG$ ) , and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , glutethimide , @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
@DRUG$ Including tranylcypromin sulfate, phenelzinsulfate and pargylin HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension .	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
Similarly dialyzed were @DRUG$, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by @DRUG$ , @DRUG$ In 16 patients receiving coumarin therapy, glutethimide, chloral hydrate and methaqualone were systematically studied.	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/phenobarbital.	DDI-false
Drug/Laboratory Test Interactions @DRUG$ , including @DRUG$ , are known to occasionally induce a positive direct coombs test.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone with vincristine plus). @DRUG$ ) without antiretroviral therapy.	DDI-false
The co-administration of alcohol and @DRUG$ does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (lovastatin, @DRUG$, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
No significant interactions were found between @DRUG$ and warfarin or @DRUG$.	DDI-false
Five days of @DRUG$ treatment did not significantly affect steady-state pharmacokinetic variables of @DRUG$ compared with placebo;	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, @DRUG$, tranquilizers).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Then, the effects of the metabotropic glutamate receptor (mGluR ) agonists, @DRUG$ and L-CCG-1 , on the above behavioral changes induced by @DRUG$ were found .	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
Other Drugs:Drugs such as @DRUG$, disopyramide, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
The effects of ruthenium red (@DRUG$) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and @DRUG$ , specifically , @DRUG$ , cis-platinum, tamoxifen and interferon alpha.	DDI-false
Moreover , additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels , and administration to a patient population chronically receiving @DRUG$ The bioavailability of digoxin compared to control data was not different.	DDI-false
Other Drugs : Drugs such as quinidine , @DRUG$ Procainamide, phenothiazine, @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Lithium: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-effect
In addition to this pharmacological interaction, this report describes a novel chemical reaction between temazepam ( @DRUG$ ) and @DRUG$ Under acidic conditions similar to found in vivo, resulting in a 3-ethoxylated product.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In addition to this pharmacological interaction , this report describes a novel chemical reaction between @DRUG$ ( a benzodiazepine ) and @DRUG$ under acidic conditions similar to those found in vivo , resulting in a 3-ethoxylated product .	DDI-mechanism
acetaminophen/theophylline, @DRUG$/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Moreover , additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels , and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data .	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and @DRUG$ in rats;	DDI-false
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and fluvastatin.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Agents Causing Renin Release: The antihypertensive effect of enalapril and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., @DRUG$).	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ Only, they modify the mitogenic effect of @DRUG$ and insulin .	DDI-false
In EM individuals treated with paroxetine or @DRUG$ , the AUC of @DRUG$ is approximately 6- to 8-fold and Css , max is about 3- to 4-fold greater than atomoxetine alone .	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$ , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Moreover, the mechanisms underlying the development of dependence may be similar for @DRUG$ and @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/@DRUG$, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Therefore , interactions could occur following concomitant administration of @DRUG$ - narcotics, analgesics, @DRUG$ , sedatives , tranquilizers ) .	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
acetaminophen/@DRUG$ , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
@DRUG$, @DRUG$, phenobarbital, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, reserpine.	DDI-effect
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin), myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g., @DRUG$ , asparaginase) effects with @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-mechanism
♪ Drugs that can change ♪ @DRUG$ Plasma concentrations Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when gleevec is administered with CYP3A4 inhibitors (e.g. @DRUG$ , itraconazole , erythromycin , clarithromycin ) .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
@DRUG$ should be administered with caution to patients receiving @DRUG$ (disulfiram, Wyeth-Ayerst Laboratories).	DDI-advise
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
Coingestion of @DRUG$ with @DRUG$, phenobarbital with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , @DRUG$ , @DRUG$ ) .	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e. cyclophosphamide, @DRUG$ , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although neither dexamethasone nor retinyl acetate proliferates in RPMI1640, @DRUG$ alone , they modify the mitogenic effect of EGF and @DRUG$.	DDI-false
@DRUG$ and @DRUG$ : a drug interaction.	DDI-int
Co-administration of @DRUG$ with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with @DRUG$ , steroids, or @DRUG$ may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
only @DRUG$ Elevated @DRUG$-induced increase in accumbal dopamine.	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and antineoplastic agents, especially dacarbazine. @DRUG$ , Tamoxifene and @DRUG$.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors ( @DRUG$ , simvastatin and @DRUG$ This leads to unique biopharmaceutical properties compared to other active substances in this class.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , vincristine , and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , phenytoin , carbamazepine , @DRUG$ , @DRUG$ or St.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , methyldopa , nitrates , @DRUG$ , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF .	DDI-effect
@DRUG$, such as verapamil, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, reserpine.	DDI-effect
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ The antitumour effectiveness of PROLEUKIN can be reduced and should therefore be avoided. 12 @DRUG$ In PROLEUKIN, hypotension and other antihypertensive agents may be increased.	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, DCG-IV and @DRUG$, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
There are 3 types of indications: specific (for the treatment of some forms of @DRUG$ deficit i.e. acute), pharmacological (i.e. without alterations of @DRUG$ status) and mixed--pharmacological and aetiopathogenic--(for example complications of chronic alcoholism).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another @DRUG$ and @DRUG$ But can be seen after several months.	DDI-effect
While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors , @DRUG$ has much lower affinities than @DRUG$ For NMDA and Sigma-2 receptors, sodium channels and the 5-HT transporter.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Concomitant use with @DRUG$s may result in the reduced absorption of @DRUG$.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital , secobarbital , @DRUG$ , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ , and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
@DRUG$ and glutethimide should not be administered to patients receiving @DRUG$.	DDI-advise
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
@DRUG$ ( ' @DRUG$ ) is a newly introduced atypical antipsychotic with proven efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
No significant interactions were found between @DRUG$ and @DRUG$ or digoxin.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients treated with acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives ( including @DRUG$ ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Patients taking @DRUG$ concomitantly with @DRUG$ more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.	DDI-effect
@DRUG$ and retinyl acetate similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
Similarly dialyzed were @DRUG$ , quinidine , and @DRUG$ , both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Concomitant administration of @DRUG$ doubled the AUC for @DRUG$.	DDI-mechanism
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Similarly dialyzed were @DRUG$ , @DRUG$ Theophylline and theophylline, both in therapeutic concentrations in serum and with ethanol in three different concentrations in serum.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ And antineoplastic agents, especially dacarbazine, cis-platinum, @DRUG$ and interferon-alfa .	DDI-effect
Although neither @DRUG$ Neither retinyl acetate influences prostatic epithelium proliferation in RPMI1640 with transferrin alone, modifying the mitogenic effect of EGF and @DRUG$.	DDI-effect
Corticosteroids, @DRUG$ and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Caution should be exercised when @DRUG$ are given in conjunction with @DRUG$.	DDI-advise
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors , e.g. , @DRUG$ , fluoxetine , and quinidine .	DDI-advise
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ Deficit and to discriminate between magnesium deficiency due to insufficient magnesium uptake, which requires only oral physiological supplement and magnesium degradation, which with a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation .	DDI-false
Based on the results of these studies, it is concluded that: @DRUG$ The use can be done with zidovudine as well as @DRUG$.	DDI-false
Corticosteroids , @DRUG$ and Diuretics : Concomitant treatment with @DRUG$ , steroids , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of warfarin and @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.	DDI-false
Potassium-sparing diuretics ( e.g. , @DRUG$ , triamterene , or amiloride ) , potassium supplements , or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Chloral hydrate and @DRUG$ interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
Acetaminophen, lidocaine, @DRUG$, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or @DRUG$).	DDI-advise
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , @DRUG$ ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Both @DRUG$ and 18-MC block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
The zidovudine study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-benzodiazepines , @DRUG$ , certain @DRUG$ ..............................................................................................................................................................................................................................................................................................................................................................................	DDI-false
The @DRUG$ are a family of @DRUG$ and hypnotic drugs.	DDI-false
@DRUG$ diminished the binding of @DRUG$ to human serum by a net change of 5.7 % ( percentage increase in free drug fraction [ FDF ] , 11.0 % ) at 662 micromol/L and by a net change of 7.1 % ( percentage increase in FDF , 13.7 % ) at 1324 micromol/L.	DDI-mechanism
These results suggest that both dexamethasone and dexamethasone @DRUG$ , and possibly other glucocorticoids and retinoids, the proliferation of prostate epithelium can be regulated by a dose-dependent change in activity of @DRUG$ and EGF .	DDI-effect
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
@DRUG$ : Concurrent administration of aspirin may lower @DRUG$ plasma levels , possibly by competing for protein-binding sites .	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, @DRUG$, and quinidine.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
It is therefore necessary to be familiar with the clinical and paraclinical pattern @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Anticoagulants including coumarin derivatives, indandion derivatives and @DRUG$ Like non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin, the risk of bleeding can be increased when administered at the same time as @DRUG$.	DDI-effect
Other concomitant therapies : In clinical trials, the safety profile in patients with acamprosate concomitantly with @DRUG$ , @DRUG$ and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
@DRUG$ or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$;	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
Simultaneous cyclophosphamide, doxorubicin, vincristine and @DRUG$ chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Warfarin : @DRUG$ Increases the effect of @DRUG$.	DDI-false
Prostatic epithelial proliferate in a defined medium, consisting of basal medium RPMI1640, containing: @DRUG$ ( 1 microgram/ml ) , EGF ( 10 ng/ml ) , and @DRUG$ [ 3.7 micrograms/ ml or 0.1 IU/ ml].	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
Like ibogaine ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of morphine and @DRUG$ The oral self-administration of @DRUG$ nicotine in rats;	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, @DRUG$, higher alcohols and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
@DRUG$ , such as verapamil , @DRUG$ and nifedipine , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
The concomitant intake of @DRUG$ and @DRUG$ The pharmacokinetics of alcohol or acamprosate are not affected.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or @DRUG$.	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered radiographic iodinated contrast media experienced acute, atypical adverse reactions.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Anticoagulants including coumarin derivatives, indandion derivatives and @DRUG$ - Non-steroidal anti-inflammatory medicinal products (NSAIDs) and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and @DRUG$, on the above behavioral changes induced by PCP were found.	DDI-false
The effects of DCG-IV and L-CCG-1 upon @DRUG$ (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
The safety and efficacy of @DRUG$ In combination with any @DRUG$ It wasn't detected.	DDI-false
Coingestion of acetaminophen with theophylline , phenobarbital with @DRUG$ , and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , @DRUG$ , @DRUG$ , rifampin , phenobarbital or St.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, methyldopa, @DRUG$ , calcium-blocking agents , hydralazine , @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Concomitant cyclophosphamide, @DRUG$, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
there was no significant change in prothrombin test results during the trials of @DRUG$ and @DRUG$.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Medicines that may alter the plasma concentration of imatinib Drugs that may increase the plasma concentration of imatinib @DRUG$ plasma concentrations : Caution is recommended when administering @DRUG$ With inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The effects of ruthenium red ( RR ) on @DRUG$ The (@DRUG$)-induced reactions were studied on megacaryocytes of the rat's bone marrow with the patch-clamp whole cell recording technique in combination with the Fura-2 microfluorometry.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , @DRUG$ , glutethimide, chloralhydrate and @DRUG$ The treatment was systematically studied in 16 patients receiving coumarin therapy.	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Like ibogaine ( 40 mg/kg ) , @DRUG$ ( 40 mg/kg ) decreases the intravenous self-administration of @DRUG$ • cocaine and oral self-administration of ethanol and nicotine in rats;	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing a high sequential dose. @DRUG$ and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and @DRUG$.	DDI-effect
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 @DRUG$ and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Acetaminophen , @DRUG$ , phenobarbital , quinidine , @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
The possibility of hypotensive effects with @DRUG$ or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
Concomitant cyclophosphamide , @DRUG$ , vincristine , and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Other cardiovascular agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , hydralazine , @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics , @DRUG$ and @DRUG$ ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Slow-channel calcium blockers, such as verapamil, @DRUG$ and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
The antihypertensive effect of Enalapril and Enalapril IV is increased by: @DRUG$ that cause renin release ( e.g. , @DRUG$ ) .	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , glutethimide , chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
As Ibogain ( 40 mg/kg ) reduces 18-MC ( 40 mg/kg ) intravenous self-administration of morphine and cocaine and oral self-administration of @DRUG$ and @DRUG$ in rats ;	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
The effects of @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, methanol, higher @DRUG$ and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
The monoamine oxidase inhibitory effects of @DRUG$ may persist for a substantial period after discontinuation of the drug, and this should be borne in mind when another drug is prescribed following @DRUG$.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
The effects of @DRUG$ ( @DRUG$ InsP(3))-induced reactions were investigated in inositol 1.4.5-trisphosphate (InsP(3))-induced megacaryocytes of the rat's bone marrow with the patch clamp whole cell recording technique in combination with the Fura-2 microfluorometry.	DDI-false
In vitro studies have shown that precipitation occurs when eye drops containing @DRUG$ are mixed with @DRUG$.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
injection of @DRUG$ (@DRUG$) were observed by measuring locomotor activity and stereotyped behavior.	DDI-false
Therefore, interactions may occur after concomitant administration of psychotropic medicinal products (e. g. @DRUG$ , analgesics, antiemetics, sedatives, @DRUG$ ) .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
There are 3 types of indications : specific ( for the treatment of some forms of @DRUG$ deficit i.e. acute ) , pharmacological ( i.e. without alterations of @DRUG$ Status) and mixed -- pharmacologically and aetiopathogen -- (for example, complications of chronic alcoholism).	DDI-false
Concomitant cyclophosphamide, doxorubicin, vincristine, and @DRUG$ chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without treatment @DRUG$ therapy .	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both @DRUG$ and dideoxyinosine.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
Dexamethasone and retinyl acetate similarly inhibit and stimulate @DRUG$- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-false
@DRUG$ had no significant effect on @DRUG$ pharmacokinetics.	DDI-false
Other medicines: medicines such as quinidine, disopyramide, @DRUG$ , phenothiazines , @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
It is concluded that @DRUG$ and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
There is a significant increase in exposure to @DRUG$ when Gleevec is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/@DRUG$, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ with vincristine plus bleomycin) without reception @DRUG$ therapy .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
The management of the local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$ , tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Medicines that cause the release of renin : The antihypertensive effect of @DRUG$ Ug and enalapril IV is supplemented by @DRUG$ that cause renin release ( e.g. , diuretics ) .	DDI-effect
Nephrotoxicity has been reported following concomitant administration of @DRUG$ and @DRUG$.	DDI-effect
Higher concentrations of @DRUG$ ( 10(-8 ) - 10(-6 ) M ) or retinyl acetate ( 3 X 10(-8 ) - 10(-7 ) M ) enhance the mitogenic activity of @DRUG$.	DDI-effect
@DRUG$    @DRUG$ antagonism	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , DCG-IV and @DRUG$ To the above behavioral changes induced by @DRUG$ were found .	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Fenfluramine may have the effect of @DRUG$ , e.g. , @DRUG$ , methyldopa, reserpine.	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
Guardians of children who have been prescribed @DRUG$ should be alerted to the general concern regarding asthma therapy compliance, especially neglect of anti-inflammatory therapy and overuse of @DRUG$.	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
- Non-selective MAO inhibitors including tranylcypromin sulfate, @DRUG$ , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension .	DDI-false
Anticoagulant inhibition was observed during the administration of phenobarbital , @DRUG$ and @DRUG$ ;	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and @DRUG$ Interaction pharmacologically with orally administered anticoagulants, but the effect is not clinically significant.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with @DRUG$ , methyldopa , @DRUG$ , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Concomitant @DRUG$, @DRUG$, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or pimozide).	DDI-advise
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Acetaminophene, lidocaine, @DRUG$ , @DRUG$ Theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium .	DDI-effect
The management of the local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or @DRUG$ may produce severe , prolonged hypotension or hypertension .	DDI-effect
@DRUG$ diminished binding of @DRUG$ by a net change of 9.9% (percentage increase in FDF, 21.2%) at 1732 micromol/L.	DDI-mechanism
The @DRUG$ Study-dose patients with 1200 mg/ day @DRUG$ ( n = 7 ) ( later changed to 600 mg/day [ n = 5 ] ) for Days 8 to 21 of a 21-day course of 100 mg , five times/day of zidovudine .	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, @DRUG$, reserpine.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Special care is recommended when administering @DRUG$ CYP3A4 substrates that have a narrow therapeutic window (e.g. @DRUG$ or pimozide ) .	DDI-advise
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine.	DDI-false
No significant interactions were found between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent @DRUG$ such as furosemide.	DDI-effect
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and @DRUG$/Phenobarbital.	DDI-false
Similarly dialyzed were @DRUG$ , quinidine, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , @DRUG$ , @DRUG$ , tranquilizers ) .	DDI-false
CYP2D6 inhibitors - @DRUG$ is primarily metabolized by the CYP2D6 pathway to @DRUG$.	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
@DRUG$ - prior ingestion of diphenidol may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ : Concurrent administration of @DRUG$ Meclopenamate sodium plasma levels can be lowered, possibly through competition for protein-binding sites.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide, and prednisone with vincristine plus). @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
Although neither dexamethasone nor @DRUG$ Influenced the proliferation of prostate epithelium in RPMI1640 with @DRUG$ Alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
The effects of ruthenium red (@DRUG$) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Other Drugs:Drugs such as @DRUG$, @DRUG$, procainamide, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Other medicines: medicines such as quinidine, disopyramide, @DRUG$ , @DRUG$ , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Although neither @DRUG$ Retinyl acetate affected prostatic epithelium proliferation in RPMI1640 with @DRUG$ Alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
The blood pressure effect of SULAR tended to be greater in patients on @DRUG$ than in patients on no other @DRUG$ therapy.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Co-administration of @DRUG$ with Acamprosate produced a 25 % increase in AUC and a 33 % increase in the Cmax of @DRUG$.	DDI-false
Primary and secondary @DRUG$ deficiencies constitute the sole indication of physiological oral @DRUG$ therapy.	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium .	DDI-effect
@DRUG$ IV has been used concomitantly with @DRUG$ without evidence of clinically significant adverse reactions.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The effects of @DRUG$ and @DRUG$ After phencyclidine (PCP)-induced movement and behavioural changes in mice.	DDI-false
This study showed that the potent cytochrome P450 enzyme inducer @DRUG$ In fact, had a significant effect on the metabolism of @DRUG$ , resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia , schizoaffective disorder , or bipolar disorder .	DDI-mechanism
Because @DRUG$ Patients who require anticoagulation should receive a low molecular weight or standard @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Both the toxicity of @DRUG$ The therapeutic value of amphotericin B can be rationalised at both cellular and molecular level by the following observations: (i ) these @DRUG$ showed differential effects on cells ;	DDI-false
Monoamine oxidase inhibitors and tricyclic antidepressants : @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ Because the effect of formoterol on the cardiovascular system can be enhanced by these active substances.	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, @DRUG$, clarithromycin).	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients with acamprosate concomitantly with @DRUG$ , hypnotics and sedatives ( including benzodiazepines ) , or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Non-steroidal Anti-inflammatory Agents : In some patients with compromised renal function who are being treated with @DRUG$ , the co-administration of @DRUG$ For this reason, further deterioration of renal function may result.	DDI-effect
Two groups (SH/DA; SH/FA) were treated daily with synthetic hydroalcoholic solutions which: @DRUG$ , methanol , higher @DRUG$ acetaldehyde and acetaldehyde in the same proportions as in the most common distilled and fermented alcoholic beverages;	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , methyldopa, nitrates, calcium blockers, hydralacin, @DRUG$ and digoxin without evidence of clinically significant adverse interactions .	DDI-false
The effect of rifampin on our patient's warfarin requirements seemed to be at most 5 to 7 days after the onset of the @DRUG$ and extended a similar length of time after @DRUG$ withdrawal .	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on @DRUG$ than in patients on no other antihypertensive therapy.	DDI-effect
Acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
@DRUG$ including coumarin derivatives , indandione derivatives , and @DRUG$ such as nonsteroidal anti-inflammatory drugs ( NSAIDs ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
The use of acetaminophene with acetaminophene @DRUG$ , phenobarbital with @DRUG$ , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Withdrawal of @DRUG$ decreased the @DRUG$ requirement by 50%.	DDI-mechanism
Potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , @DRUG$ Food supplements or salt substitutes containing @DRUG$ may lead to a significant increase in serum potassium.	DDI-false
Lack of an effect of azithromycin on the disposition of @DRUG$ and @DRUG$ in HIV-infected patients.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by @DRUG$ , secobarbital , glutethimide , chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
@DRUG$ , Methylxanthines and @DRUG$ : Concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
However , @DRUG$ Speeded up, but not significantly inhibited, proliferation in the presence of @DRUG$.	DDI-effect
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , @DRUG$ - Nitrates, calcium blockers, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
Both ibogaine and @DRUG$ block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
The use of local anesthetics containing epinephrine, or @DRUG$ to patients receiving monoamine oxidase inhibitors , @DRUG$ or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-effect
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of Gleevec, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
The pharmacokinetics of naltrexone and its major metabolite @DRUG$ were unaffected following co-administration with @DRUG$.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine, and @DRUG$ CHOP chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These results suggest that the hepatoxicity of @DRUG$ in alcoholic beverages is enhanced by interaction with its congeners and @DRUG$;	DDI-effect
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$ , doxorubicin , @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Further , no effects on either @DRUG$ In a study with concomitant administration of warfarin and @DRUG$, levels or prothrombin times were observed.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
* Anticoagulants including coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as: @DRUG$ ( @DRUG$ Aspirin may increase the risk of bleeding when administered at the same time as ardeparin.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Corticosteroids , @DRUG$ • Aus- and diuretics: concomitant treatment with xanthine derivatives, @DRUG$ Diuretics may potentiate a possible hypocalemic effect of beta2-agonists.	DDI-false
Among the @DRUG$ , many, like @DRUG$ , can not be used clinically because they are toxic;	DDI-false
@DRUG$ has been reported to increase the @DRUG$ requirements in human subjects ingesting these agents simultaneously.	DDI-mechanism
@DRUG$ "Seroquel" is a newly introduced @DRUG$ With proven efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
@DRUG$ Retinyl acetate also inhibits and stimulates EGF or @DRUG$-induced prostatic epithelium proliferation.	DDI-effect
The use of local anesthetics containing epinephrine, or @DRUG$ to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or @DRUG$ For this reason, severe, prolonged hypotension or hypertension may occur.	DDI-effect
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., diuretics).	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients with @DRUG$ - together with anxiolytics, @DRUG$ and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Myocardial injury, including myocardial infarction, myocarditis, ventricular hypokinesia, and severe rhabdomyolysis appear to be increased in patients receiving @DRUG$ and @DRUG$ concurrently.	DDI-effect
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
How ibogain ( 40 mg/kg ) reduces intravenous self-injection of 18-MC ( 40 mg/kg ) @DRUG$ and cocaine and the oral self-administration of @DRUG$ nicotine in rats;	DDI-false
Lithium: Lithium toxicity has been reported in patients who: @DRUG$ concomitantly with drugs which cause elimination of sodium , including @DRUG$.	DDI-effect
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Coingestion of @DRUG$ with @DRUG$ , phenobarbital with acetaminophene, and valproic acid with phenobarbital at high to toxic concentrations reduces binding of the target drug.	DDI-effect
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with @DRUG$ , @DRUG$ Diuretics may potentiate a possible hypocalemic effect of beta2-agonists.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Medicines that may alter the plasma concentration of imatinib Drugs that may increase the plasma concentration of imatinib @DRUG$ Plasma concentrations: Caution should be exercised when gleevec is administered with inhibitors of the CYP3A4 family (e.g. ketoconazole, @DRUG$ Erythromycin, clarithromycin, erythromycin, erythromycin, erythromycin.	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , @DRUG$ , reserpine .	DDI-effect
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors , 18-MC has much lower affinities than @DRUG$ For NMDA and Sigma-2 receptors, sodium channels and the 5-HT transporter.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$ , the proliferation of prostate epithelium can be regulated by a dose-dependent change in the activity of @DRUG$ and EGF .	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e. cyclophosphamide, @DRUG$ , teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Coingestion of @DRUG$ with theophylline, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
It is concluded that @DRUG$ and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
Barbiturates and @DRUG$ should not be administered to patients receiving @DRUG$.	DDI-advise
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
These results suggest that both @DRUG$ Retinyl acetate and possibly other glucocorticoids and @DRUG$ Prostate epithelium proliferation can be controlled by dose-dependent changes in insulin and EGF activity.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e. cyclophosphamide, doxorubicin, @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , @DRUG$ , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
Acetaminophen , @DRUG$ , @DRUG$ , quinidine , theophylline , and valproic acid were added to pooled human serum at therapeutic concentrations .	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by @DRUG$ , secobarbital , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Aspirin: Concurrent administration of @DRUG$ may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-mechanism
Co-administration of @DRUG$ with @DRUG$ produced a 25 % increase in AUC and a 33 % increase in the Cmax of acamprosate .	DDI-mechanism
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ Beta-blockers and other antihypertensive agents may increase the hypotension observed with PROLEUKIN.	DDI-false
Acetaminophene, lidocaine, @DRUG$ , quinidine , @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or enalaprilat.	DDI-effect
, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/phenobarbital.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
The hypoglycemic effect of @DRUG$ has been reported to increase when @DRUG$ is given concurrently.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Nephrotoxicity following co-administration of cephalosporins with @DRUG$ Or potent diuretics like @DRUG$.	DDI-false
Although @DRUG$ have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with @DRUG$ - together with anxiolytics, hypnotic agents and sedatives (including benzodiazepines), or @DRUG$ It was similar in patients taking placebo with these concomitant medications as in patients receiving placebo.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
Simultaneous use of other @DRUG$ may potentiate the undesirable effects of @DRUG$.	DDI-effect
The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or @DRUG$.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and quinidine.	DDI-advise
The safety and efficacy of @DRUG$ in combination with any @DRUG$ have not been established.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or @DRUG$.	DDI-false
Concomitant @DRUG$ , doxorubicin , vincristine , and prednisone chemotherapy plus @DRUG$ Treatment in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma.	DDI-false
In a clinical pharmacology study, indomethacin or @DRUG$ was administered to hypertensive patients receiving @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , @DRUG$ , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
The effects of ruthenium red (RR) on @DRUG$ (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
The effects of ruthenium red ( @DRUG$ ) on @DRUG$ ( InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry .	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
The results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume @DRUG$ and @DRUG$ on a regular basis.	DDI-mechanism
Hypotension : patients receiving diuretic therapy : patients below @DRUG$ Especially those who have recently started diuretic therapy may occasionally experience an excessive reduction in blood pressure after initiation of Enalapril or @DRUG$ therapy.	DDI-effect
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
The use of local anaesthetics containing epinephrine or norepinephrine in patients who: @DRUG$ , @DRUG$ or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or with a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone). @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
Molecular basis for the selective toxicity of @DRUG$ for yeast and @DRUG$ for animal cells.	DDI-false
Potassium-sparing diuretics ( e.g. , @DRUG$ , triamterene , or amiloride ) , @DRUG$ supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, methyldopa, @DRUG$ - Calcium blockers, @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Fenfluramine may have the effect of @DRUG$ , e.g. , guanethidine , methyldopa , @DRUG$.	DDI-false
Moreover , additional interaction studies with @DRUG$ Propranolol and propranolol have no effect on @DRUG$ Plasma levels and administration to a patient population receiving chronic digoxin did not differ in the extent of bioavailability of digoxin compared to control data.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ Insufficient magnesium intake, which requires only oral physiological supplement and magnesium deficiency, with a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-@DRUG$ , dihydropyridine calcium channel blockers , certain HMG-CoA reductase inhibitors , etc . ) .	DDI-mechanism
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with @DRUG$ • or tricyclic antidepressants, because the effect of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
The intensity , uniformity and time course of @DRUG$ interference by phenobarbital , secobarbital , glutethimide , @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and @DRUG$.	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin), myelotoxic (e.g., @DRUG$ Chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
It is concluded that @DRUG$ and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy .	DDI-false
A dose adjustment of STRATTERA may be required when co-administered with CYP2D6 inhibitors, e.g. @DRUG$ , fluoxetine , and @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , @DRUG$ chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ Asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of the magnesium deficiency and to distinguish between magnesium deficiency due to insufficient magnesium uptake, which requires only an oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of @DRUG$ Status that requires more or less specific regulation of its causal dysregulation.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant administration of these agents with PROLEUKIN may reduce the efficacy of antitumours. @DRUG$ and thus should be avoided . 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN .	DDI-false
No significant interactions were found between @DRUG$ and warfarin or @DRUG$.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , @DRUG$ , @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
The coingestion of acetaminophen with theophylline, @DRUG$ - with acetaminophene and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
In vitro studies have shown that precipitation occurs when eye drops containing @DRUG$ The mixture is done with @DRUG$.	DDI-false
@DRUG$ including @DRUG$ , phenelzine sulfate , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ Before starting treatment with @DRUG$ or enalaprilat .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-effect
Other cardiovascular agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
This effect may be mediated by the ability of @DRUG$ It is used to induce microsomal enzymes and thus the catabolism of @DRUG$.	DDI-mechanism
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
In addition, additional interaction studies with niacin and @DRUG$ They have no effect on @DRUG$ Plasma levels and administration to a patient population receiving chronic digoxin did not differ in the extent of bioavailability of digoxin compared to control data.	DDI-false
Coadministration of @DRUG$ with 40 mg @DRUG$ tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels .	DDI-mechanism
Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or @DRUG$).	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone). @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
@DRUG$ ==References====External links== @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
The benzodiazepines are a family of @DRUG$ and @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/@DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Effect of @DRUG$ on the pharmacokinetics of @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The possibility of hypotensive effects with @DRUG$ or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by phenobarbital, @DRUG$ , glutethimide , @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
injection of @DRUG$ ( @DRUG$ ) were observed by measuring locomotor activity and stereotyped behavior .	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or @DRUG$.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, @DRUG$, rifampin, phenobarbital or St.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
These results suggest that both dexamethasone and @DRUG$ , and possibly other glucocorticoids and @DRUG$ , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF .	DDI-false
@DRUG$/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
The effects of concomitant @DRUG$ @DRUG$ steady-state pharmacokinetic application.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, co-administration of these active substances with PROLEUKIN may reduce the efficacy of PROLEUKIN against the tumour and should therefore be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-effect
@DRUG$ had a similar effect in the presence of @DRUG$.	DDI-false
Acetaminophene, lidocaine, @DRUG$ , quinidine, theophylline, and @DRUG$ The pooled human serum was added at therapeutic concentrations.	DDI-false
The effect of @DRUG$ on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal.	DDI-effect
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, methyldopa, @DRUG$ , calcium-blocking agents , hydralazine , prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window ( e.g. , @DRUG$ or @DRUG$ ) .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Therefore , interactions could occur following concomitant administration of @DRUG$ ( e.g. , @DRUG$ , analgesics , antiemetics , sedatives , tranquilizers ) .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Acute symptoms should be treated with a short-acting , inhaled   @DRUG$ such as @DRUG$ (The doctor should provide the patient with such medication and instruct the patient how to use it).	DDI-false
Atromid-S may displace acidic drugs such as @DRUG$ or @DRUG$ from their binding sites.	DDI-false
@DRUG$ : @DRUG$ Toxicity has been reported in patients receiving lithium concomitantly with medicinal products that cause the excretion of sodium, including ACE inhibitors.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
• Delayed adverse reactions to iodised contrast media : A review of the literature revealed that 12.6% ( range 11 - 28% ) of the 501 patients who had various @DRUG$ containing regimens who were subsequently administered @DRUG$ There were acute, atypical side effects.	DDI-effect
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Anticoagulants such as coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as non-steroidal anti-inflammatory drugs (NSAIDs) and @DRUG$ When co-administered with @DRUG$, the risk of bleeding can be increased.	DDI-effect
@DRUG$ - Before taking diphenidol, the emetic response to @DRUG$ in the treatment of poisoning .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ Methaqualone is pharmacologically interacting with orally administered @DRUG$ However, the effect is not clinically significant.	DDI-int
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with xanthine derivatives , @DRUG$ Diuretics may potentiate a possible hypokalemic effect @DRUG$	DDI-effect
For these reasons, it is felt that, in most subjects who have had an unsatisfactory lipid response to either drug alone, the possible benefits of combined therapy with @DRUG$ and a @DRUG$ do not outweigh the risks of severe myopathy, rhabdomyolysis, and acute renal failure.	DDI-effect
In EM individuals treated with @DRUG$ or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide , and prednisone with vincristine plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, phenothiazines, @DRUG$, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent @DRUG$ such as furosemide.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/phenobarbital.	DDI-false
Two groups ( SH/DA ; SH/FA ) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$ , methanol, higher alcohols and @DRUG$ — in the same proportions as in the most frequently distilled and fermented alcoholic beverages;	DDI-false
Lack of an effect of @DRUG$ On the disposition of @DRUG$ - and dideoxyinosin in HIV infected patients.	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ , @DRUG$ , hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Both ibogaine and @DRUG$ • Block @DRUG$-induced and nicotine-induced dopamine release in the core accumbens;	DDI-effect
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-benzodiazepines , @DRUG$ , certain HMG-CoA reductase inhibitors , etc . ) .	DDI-mechanism
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ The depletion associated with a dysregulation of the control mechanisms of magnesium status, which requires more or less specific regulation of its causal dysregulation.	DDI-false
In addition, we have shown that @DRUG$ is a useful pharmacological tool with which to examine the @DRUG$-mediated responses of megakaryocytes.	DDI-false
These results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and @DRUG$ , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a @DRUG$) and ethanol under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors , @DRUG$ The affinities for NMDA and Sigma-2 receptors, sodium channels and 5-HT transporters are significantly lower than ibogain.	DDI-false
Coingestion of acetaminophen with @DRUG$, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Other concomitant therapies : In clinical studies, the safety profile in patients with acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines) or @DRUG$ It was similar in patients taking placebo with these concomitant medications as in patients receiving placebo.	DDI-false
Like @DRUG$ 18-MC ( 40 mg/kg ) reduces intravenous self-injection of @DRUG$ • cocaine and oral self-administration of ethanol and nicotine in rats;	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
To assess the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone). @DRUG$ plus @DRUG$ ) without antiretroviral therapy.	DDI-false
It is structurally distinct from the other currently available @DRUG$ ( lovastatin , simvastatin , and @DRUG$ This leads to unique biopharmaceutical properties compared to other active substances in this class.	DDI-false
Both @DRUG$ and 18-MC block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
It is structurally distinct from the other currently available @DRUG$ (lovastatin, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-effect
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), @DRUG$ (10 ng/ml), and insulin (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
Coingestion of acetaminophen with theophylline , @DRUG$ with acetaminophene and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Patients taking @DRUG$ concomitantly with @DRUG$ more commonly reported both weight gain and weight loss , compared with patients taking either medication alone .	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving @DRUG$ therapy.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and @DRUG$ chemotherapy therapy plus HAART with a group of 80 patients treated with CHOP chemotherapy or with a CHOP-like regimen (e.g. cyclophosphamide, doxorubicin, tenipide), and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , @DRUG$/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
@DRUG$/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium .	DDI-effect
Both @DRUG$ and 18-MC decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
@DRUG$ (e.g. spironolactone, triamterene or amilorid), @DRUG$ Supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
It is concluded that chloral hydrate and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
@DRUG$ diminished the binding of @DRUG$ to human serum by a net change of 5.7% (percentage increase in free drug fraction [FDF], 11.0%) at 662 micromol/L and by a net change of 7.1% (percentage increase in FDF, 13.7%) at 1324 micromol/L.	DDI-mechanism
Like ibogain ( 40 mg/kg), @DRUG$ ( 40 mg/kg ) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats ;	DDI-false
@DRUG$, such as @DRUG$, diltiazem and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
The concomitant intake of alcohol and @DRUG$ • Does not affect the pharmacokinetics of @DRUG$ or acamprosate .	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The initiation of @DRUG$ or @DRUG$ The use can be triggered by similar personality traits of the user, such as impulsiveness and search for sensations.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
@DRUG$ It has been shown that these are antagonistic beta-lactam antibiotics, including @DRUG$ , based on in vitro studies and time-killing curves with enteric gram-negative bacilli.	DDI-effect
@DRUG$, lidocaine, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
Therefore, if Meclofenamate sodium is given to a patient who: @DRUG$ , the dosage of @DRUG$ To prevent excessive prolongation of prothrombin time, the dose should be reduced.	DDI-false
Coadministration of @DRUG$ with 40 mg SULAR tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Other cardiovascular agents : enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other @DRUG$ Hypotension observed with PROLEUKIN may be increased.	DDI-false
- slow channel calcium blockers, such as verapamil, @DRUG$ and @DRUG$ , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Although neither dexamethasone nor @DRUG$ Influenced the proliferation of prostate epithelium in RPMI1640 with transferrin alone, modifying the mitogenic effect of @DRUG$ and insulin .	DDI-effect
Therefore, interactions following concomitant administration of psychotropic medicinal products (e.g. narcotics, @DRUG$ , antiemetics , @DRUG$ , sedatives).	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( @DRUG$ ) , and @DRUG$ The risk of bleeding may be increased when co-administered with ardeparin.	DDI-false
@DRUG$ , an anionic-binding resin , has a considerable effect in lowering the rate and extent of @DRUG$ bioavailability .	DDI-mechanism
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Coadministration of @DRUG$ with 40 mg @DRUG$ tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.	DDI-mechanism
The application of local anaesthetic solutions that @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-false
The immediate release, but not the coat-core formulation of @DRUG$ increased plasma @DRUG$ concentrations by about 20%.	DDI-mechanism
♪ Drugs that can change ♪ @DRUG$ Medicines that may increase the plasma concentration of imatinib: Caution is recommended when administering imatinib @DRUG$ With inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including @DRUG$ ) , or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Therefore, interactions after concomitant use of @DRUG$ ( e.g. , narcotics , analgesics , antiemetics , sedatives , @DRUG$ ) .	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Physiological oral @DRUG$ supplementation (5 mg/kg/day) is easy and can be carried out in the diet or with @DRUG$s, with practically only one contra-indication: overt renal failure.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
The management of the local @DRUG$ containing epinephrine or @DRUG$ Patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazine may experience severe, prolonged hypotension or hypertension.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/@DRUG$.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
It is concluded that chloral hydrate and @DRUG$ When monitoring prothrombin tests during oral administration, administration can be done without additional caution. @DRUG$ therapy .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Pre-treatment of megakaryocytes with extracellular @DRUG$ * ( 50 microM ) also inhibited @DRUG$-induced reactions.	DDI-effect
acetaminophen/theophylline, @DRUG$/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The effects of @DRUG$ (RR) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and L-CCG-1, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
@DRUG$ • the effect of @DRUG$ ==References====External links==* Official website	DDI-effect
Caution should be exercised when: @DRUG$ It is specified in connection with @DRUG$.	DDI-advise
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide, and @DRUG$ with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Acetaminophen, @DRUG$, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
The pharmacokinetics of @DRUG$ and its major metabolite 6-beta-naltrexol were unaffected following co-administration with @DRUG$.	DDI-false
Concomitant @DRUG$ , doxorubicin , @DRUG$ , and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern of the magnesium deficit and between @DRUG$ Deficiency due to insufficient absorption of magnesium, which requires only an oral physiological supplement and @DRUG$ The depletion associated with a dysregulation of the control mechanisms of magnesium status, which requires more or less specific regulation of its causal dysregulation.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
), phenobarbital/acetaminophen, phenobarbital/ valproic acid, quinidine/ lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Fenfluramine may slightly increase the effect of antihypertensive agents, e.g. @DRUG$ , @DRUG$ , reserpine .	DDI-false
Higher concentrations of dexamethasone ( 10(-8 ) - 10(-6 ) M ) or @DRUG$ ( 3 X 10(-8 ) - 10(-7 ) M ) enhance the mitogenic activity of @DRUG$.	DDI-effect
@DRUG$ , methylxanthine and diuretics: concomitant treatment with xanthine derivatives, @DRUG$ , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
@DRUG$ , @DRUG$ Abs and diuretics: Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a potential hypocalemic effect of beta2-agonists.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
- corticosteroids, methylxanthine and @DRUG$ ; Concomitant treatment with xanthine derivatives, steroids or @DRUG$ may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
@DRUG$ , lidocaine , phenobarbital , @DRUG$ Theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or @DRUG$ may produce severe , prolonged hypotension or hypertension .	DDI-effect
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , @DRUG$ , @DRUG$ , calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Like ibogain ( 40 mg/kg), @DRUG$ ( 40 mg/kg ) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats ;	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing transferrin (1 microgram/ml), @DRUG$ (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Acetaminophen/@DRUG$, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high-dose PROLEUKIN and antineoplastic agents, in particular: @DRUG$ , cis-platinum, tamoxifen and @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and antineoplastic agents, especially dacarbazine, cis-platinum. @DRUG$ and @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , @DRUG$ Myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate, asparaginase) effects with: @DRUG$ may increase toxicity in these organ systems .	DDI-effect
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$ diminished binding of @DRUG$ by a net change of 9.9 % ( percentage increase in FDF , 21.2 % ) at 1732 micromol/L.	DDI-mechanism
Other concomitant therapies : In clinical trials, the safety profile in patients treated with acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives ( including benzodiazepines ) , or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$ , @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
@DRUG$ , Methylxanthines and Diuretics : Concomitant treatment with @DRUG$ Steroids, or diuretics may potentiate a potential hypocalemic effect of beta2-agonists.	DDI-false
The effect of rifampin on the @DRUG$ The need of our patient seemed to be maximum 5 to 7 days after the induction of rifampin and extended a similar length of time after @DRUG$ withdrawal .	DDI-false
Both @DRUG$ and @DRUG$ • Improvement of locomotor and/or stereotypical effects of stimulants.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, @DRUG$, carbamazepine, rifampin, phenobarbital or St.	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
No significant interactions were found between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors , e.g. , @DRUG$ , @DRUG$ , and quinidine .	DDI-false
@DRUG$ Patients receiving @DRUG$ should not receive glutethimide treatment.	DDI-advise
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
Other cardiovascular agents : enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , @DRUG$ Nitrates, calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Delayed Adverse Reactions to Iodinated Contrast Media: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-effect
In addition, additional interaction studies with: @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels , and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ Relative to the control data.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Co-administration of @DRUG$ with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.	DDI-mechanism
Other cardiovascular agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Pretreatment of megakaryocytes with extracellular @DRUG$ (50 microM) also inhibited @DRUG$-induced responses.	DDI-effect
It is important that patients understand how to use @DRUG$  (@DRUG$) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking.	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
- monoamine oxidase inhibitors, and @DRUG$ FORADIL should be used with extreme caution in patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, as the effect of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
It differs structurally from the other HMGCoA reductase inhibitors currently available ( lovastatin, @DRUG$ , and @DRUG$ This leads to unique biopharmaceutical properties compared to other active substances in this class.	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents : Enalapril and @DRUG$ IV were co-administered with beta-adrenerg blockers, methyldopa, nitrates, calcium blockers, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$      @DRUG$ antagonism	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Ibogain as well as 18-MC block @DRUG$-induced and @DRUG$-induced dopamine release in nucleus accumbens;	DDI-false
This effect may be mediated by the ability of @DRUG$ to induce microsomal enzymes and, thus, the catabolism of @DRUG$.	DDI-mechanism
Acetaminophene, lidocaine, phenobarbital, @DRUG$ , theophylline, and @DRUG$ The pooled human serum was added at therapeutic concentrations.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ with @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
The use of acetaminophene with acetaminophene @DRUG$ , phenobarbital with acetaminophene and @DRUG$ The binding of the target medication is reduced with phenobarbital at high to toxic concentrations.	DDI-false
Co-medicines that induce CYP3A4 (e.g. @DRUG$ , phenytoin , @DRUG$ , rifampin, phenobarbital or St.	DDI-false
Molecular basis for selective toxicity of @DRUG$ for yeast and @DRUG$ for animal cells .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Slow-channel calcium blockers, such as @DRUG$, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
In EM individuals treated with paroxetine or fluoxetine , the AUC of @DRUG$ is approximately 6- to 8-fold and Css , max is about 3- to 4-fold greater than @DRUG$ alone .	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Co-medications that induce CYP3A4 ( e.g. , @DRUG$ , phenytoin , carbamazepine , @DRUG$ , phenobarbital or St.	DDI-false
The bioavailability of the capsule formulation of @DRUG$ The effect was not affected by administration of 5 minutes after @DRUG$.	DDI-false
therefore , the use of @DRUG$ Not required is an adjustment in @DRUG$ dose to maintain therapeutic digoxin levels .	DDI-false
Agents Causing Renin Release : The antihypertensive effect of enalapril and @DRUG$ IV is augmented by @DRUG$ that cause renin release ( e.g. , diuretics ) .	DDI-effect
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine , although it significantly decreased the zidovudine tmax by 44 % and increased the intracellular exposure to phosphorylated @DRUG$ - 110%.	DDI-mechanism
These results suggest that both @DRUG$ and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Therefore, interactions may occur after concomitant administration of psychotropic medicinal products (e. g. @DRUG$ , analgesics , @DRUG$ , sedatives, sedatives).	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
Physiological oral @DRUG$ load constitutes the best tool for diagnosis of @DRUG$ deficiency and the first step of its treatment.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with acetaminophen, and @DRUG$ with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ Plasma concentrations : Caution should be exercised when gleevec is administered with inhibitors of the CYP3A4 family (e.g. @DRUG$ , itraconazole , erythromycin , clarithromycin ) .	DDI-false
@DRUG$ • 150 mg twice daily did not significantly interact with @DRUG$ The AUC was reduced by 15 - 20 %.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Effect of @DRUG$ on the pharmacokinetics of @DRUG$.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and @DRUG$.	DDI-false
Although this effect was noted even when @DRUG$ was given 4 hours prior to @DRUG$, this regimen did not result in diminished efficacy.	DDI-effect
@DRUG$ - prior ingestion of @DRUG$ may decrease the emetic response to apomorphine in the treatment of poisoning.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, @DRUG$, phenobarbital or St.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and @DRUG$.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or acamprosate .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , @DRUG$ , teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate , and possibly other @DRUG$ and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF .	DDI-false
Although neither dexamethasone nor @DRUG$ Influenced the proliferation of prostate epithelium in RPMI1640 with transferrin alone, modifying the mitogenic effect of EGF and @DRUG$.	DDI-effect
The effect of rifampin on the @DRUG$ The need of our patient seemed to be a maximum of 5 to 7 days after the start of treatment. @DRUG$ A similar length of time after rifampin withdrawal is prolonged and prolonged.	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
Although neither @DRUG$ nor @DRUG$ Influences the proliferation of prostate epithelium in RPMI1640 with transferrin alone, altering the mitogenic effect of EGF and insulin.	DDI-false
@DRUG$ Anticholinergic effects can be increased if these drugs are combined with @DRUG$ ;	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation .	DDI-false
However , reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ The drug metabolism in MS patients is not known.	DDI-false
The intensity, uniformity and time course of @DRUG$ The interference with phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone has been systematically studied in 16 patients who: @DRUG$ therapy .	DDI-false
@DRUG$ ( e.g. , @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), EGF (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
@DRUG$ ('@DRUG$') is a newly introduced atypical antipsychotic with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$ , specifically , dacarbazine , cis-platinum , tamoxifen and @DRUG$.	DDI-false
• Concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin), myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. @DRUG$ ) or hepatotoxic (e.g. methotrexate, @DRUG$ ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-advise
Physiological oral @DRUG$ Load provides the best tool for diagnosing @DRUG$ Deficiency and the first step of his treatment.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Other Cardiovascular Agents : @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ Patients who: @DRUG$ ( disulfiram , Wyeth-Ayerst Laboratories ) .	DDI-advise
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, @DRUG$ Myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. @DRUG$ Hepatotoxic (e.g. methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , @DRUG$ , sedatives , @DRUG$ ) .	DDI-false
The effects of @DRUG$ (@DRUG$) on inositol 1,4,5-trisphosphate (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
There were no significant interactions between: @DRUG$ and @DRUG$ or digoxin .	DDI-false
For these reasons , it is felt that , in most subjects who have had an unsatisfactory lipid response to either drug alone , the possible benefits of combined therapy with @DRUG$ and a @DRUG$ do not outweigh the risks of severe myopathy , rhabdomyolysis , and acute renal failure .	DDI-effect
hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high-dose PROLEUKIN and antineoplastic agents, in particular: @DRUG$ , cis-platinum , @DRUG$ and interferon-alfa .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient @DRUG$ The intake, which requires only oral physiological supplement and magnesium deficiency, related to a dysregulation of the control mechanisms of magnesium status, which requires more or less specific regulation of its causal dysregulation.	DDI-false
The data suggest that @DRUG$ has a narrower spectrum of actions and will have a substantially greater therapeutic index than @DRUG$.	DDI-false
Both ibogaine and @DRUG$ block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens ;	DDI-effect
Anticoagulant inhibition was observed during the administration of @DRUG$, secobarbital and @DRUG$;	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$, @DRUG$ and glutethimide;	DDI-false
@DRUG$ and @DRUG$ interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of the magnesium deficiency and to discriminate between magnesium deficiency due to insufficient @DRUG$ Ingestion that requires only oral physiological supplement and magnesium deficiency, which is accompanied by a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation .	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent diuretics such as @DRUG$.	DDI-effect
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, in particular: @DRUG$ , cis-platinum, tamoxifen and interferon alpha.	DDI-effect
Other drugs : Drugs like @DRUG$ , disopyramide, procainamide, @DRUG$ , antihistamines and tricyclic antidepressants may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
There is a significant increase in exposure to imatinib when @DRUG$ is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-mechanism
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and @DRUG$.	DDI-false
Although @DRUG$ It has been shown that PROLEUKIN-induced adverse reactions such as fever, renal insufficiency, hyperbilirubinaemia, confusion and dyspnoea are reduced, the concomitant administration of these active substances with PROLEUKIN can reduce the antitumour effectiveness of PROLEUKIN and should therefore be avoided. 12 beta-blockers and other antihypertensives may increase hypotension in @DRUG$.	DDI-false
@DRUG$ , such as @DRUG$ , diltiazem and nifedipine , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Like @DRUG$ (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$ : @DRUG$ In patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, the use should be carried out with extreme caution as the effect of formoterol on the cardiovascular system may be enhanced by these agents.	DDI-false
Concurrent use with @DRUG$ Significant elimination by active renal tubular secretion may lead to increased plasma concentrations of @DRUG$.	DDI-mechanism
@DRUG$ may increase slightly the effect of antihypertensive drugs , e.g. , @DRUG$ , methyldopa , reserpine .	DDI-effect
Other Drugs : Drugs such as quinidine , disopyramide , @DRUG$ , phenothiazine, antihistamines and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
@DRUG$ : Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including @DRUG$.	DDI-false
The blood pressure effect of SULAR was observed in patients with @DRUG$ than in patients on no other @DRUG$ therapy .	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
The pharmacokinetics of @DRUG$ ♪ And his main metabolite ♪ @DRUG$ After co-administration with acamprosate, the treatment was unaffected.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Chloral hydrate and @DRUG$ Interaction pharmacologically with orally administered @DRUG$ However, the effect is not clinically significant.	DDI-int
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
@DRUG$ and @DRUG$ should not be administered to patients receiving coumarin drugs.	DDI-false
These results suggest that both @DRUG$ and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
@DRUG$ , methylxanthine and diuretics: Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a possible hypocalemic effect @DRUG$	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Therefore, interactions after concomitant use of @DRUG$ ( e.g. , narcotics , analgesics , antiemetics , @DRUG$ , sedatives).	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , @DRUG$ chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , @DRUG$ ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Other Drugs : Drugs such as @DRUG$ , @DRUG$ Procainamide, phenothiazine, antihistamines and tricyclic antidepressants may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
The toxicity of Filipin as well as the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations : ( i ) these @DRUG$ · showed differential effects on the cells ;	DDI-false
Like @DRUG$ 40 mg/kg and 18-MC ( 40 mg/kg) reduce intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats ;	DDI-false
Corticosteroids , Methylxanthines and @DRUG$ : Accompanying treatment with xanthine derivatives, @DRUG$ Diuretics may potentiate a possible hypocalemic effect of beta2-agonists.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
The initiation of @DRUG$ or @DRUG$ use may be precipitated by similar personality characteristics in the user, such as impulsivity and sensation seeking.	DDI-false
Pre-treatment of healthy volunteers with multiple doses @DRUG$ followed by a single dose of Gleevec , increased @DRUG$ Oral dose clearance was reduced by 3.8-fold, significantly reducing the mean cmax and AUC(0-8) (p 0.05).	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , @DRUG$ or @DRUG$ For this reason, severe, prolonged hypotension or hypertension may occur.	DDI-false
The effects of DCG-IV and L-CCG-1 upon @DRUG$ (@DRUG$)-induced locomotion and behavioral changes in mice .	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , @DRUG$/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
* Delayed side effects on @DRUG$ A review of the literature showed that 12.6% (range 11 - 28 %) of 501 patients with various @DRUG$ containing regimens who were subsequently administered radiographic iodinated contrast media experienced acute , atypical adverse reactions .	DDI-false
- Non-selective MAO inhibitors including tranylcypromin sulfate, @DRUG$ , and @DRUG$ HC1 : Concurrent use of L-tyrosine and non-selective MAO inhibitors may lead to high blood pressure.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
therefore, the use of @DRUG$ does not necessitate an adjustment in @DRUG$ dose to maintain therapeutic digoxin levels.	DDI-false
Coadministration of phenytoin with 40 mg @DRUG$ tablets in epileptic patients lowered the @DRUG$ Plasma concentrations up to undetectable concentrations.	DDI-false
@DRUG$ has been reported to increase the @DRUG$ Requirements for human subjects taking these agents at the same time.	DDI-mechanism
@DRUG$ including tranylcypromine sulfate , phenelzine sulfate , and pargyline HC1 : Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension .	DDI-false
apomorphine - prior ingestion of diphenidol may decrease the @DRUG$ response to @DRUG$ in the treatment of poisoning .	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
@DRUG$ and @DRUG$ Similarly, EGF or insulin-induced proliferation of prostate epithelium is inhibited and stimulated.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
• The intake of acetaminophene with theophylline, phenobarbital with @DRUG$ , and @DRUG$ The binding of the target medication is reduced with phenobarbital at high to toxic concentrations.	DDI-false
Two groups (SH/DA; SH/FA) were treated daily with synthetic hydroalcoholic solutions which: @DRUG$ , @DRUG$ , higher alcohols and acetaldehyde in the same proportions as in the most common distilled and fermented alcoholic beverages;	DDI-false
Exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of @DRUG$ and @DRUG$, including crescentic IgA glomerulonephritis, oculo-bulbar myasthenia gravis, inflammatory arthritis, thyroiditis, bullous pemphigoid, and Stevens-Johnson syndrome.	DDI-effect
Isocarboxazid should be used with caution in patients who: @DRUG$ ( @DRUG$ ==References====External links==	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
The conversion of @DRUG$ to @DRUG$ is catalyzed by aldehyde oxidase.	DDI-false
Guardians of children who have been prescribed @DRUG$ should be alerted to the general concern regarding asthma therapy compliance , especially neglect of anti-inflammatory therapy and overuse of @DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , @DRUG$/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations : ( i ) these polyene antibiotics showed differential effects on cells ;	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-mechanism
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with @DRUG$ concomitantly with @DRUG$ Hypnotics and sedatives (including benzodiazepines) or non-opioid analgesics were similar to those in patients receiving placebo with these concomitant drugs.	DDI-false
Concomitant cyclophosphamide , @DRUG$ , @DRUG$ , and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Other Cardiovascular Agents : Enalapril and @DRUG$ IV have been used concomitantly with @DRUG$ , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
